Expandable support device and method of use

Information

  • Patent Grant
  • 11051954
  • Patent Number
    11,051,954
  • Date Filed
    Monday, July 24, 2017
    7 years ago
  • Date Issued
    Tuesday, July 6, 2021
    3 years ago
Abstract
An expandable support device for tissue repair is disclosed. The device can be used to repair hard or soft tissue, such as bone or vertebral discs. A method of repairing tissue is also disclosed. The device and method can be used to treat compression fractures. The compression fractures can be in the spine. The device can be deployed by compressing the device longitudinally resulting in radial expansion.
Description
BACKGROUND OF THE INVENTION
1. Field of the Invention

This invention relates to devices for providing support for biological tissue, for example to fuse vertebral bodies, repair herniated discs, and/or repair spinal compression fractures, and methods of using the same.


2. Description of Related Art

Some conditions of the spine result from degradation or injury to the bone structures of the spine, typically the vertebral body. These can be the result of bone degeneration such as through osteoporosis or trauma, such as compression fractures. breakdown or injury to the boney structures in the spine can result in pain and spinal deformity with comorbidities.


Vertebroplasty is an image-guided, minimally invasive, nonsurgical therapy used to strengthen a broken vertebra that has been weakened by disease, such as osteoporosis or cancer. Vertebroplasty is often used to treat compression fractures, such as those caused by osteoporosis, cancer, or stress.


Vertebroplasty is often performed on patients too elderly or frail to tolerate open spinal surgery, or with bones too weak for surgical spinal repair. Patients with vertebral damage due to a malignant tumor may sometimes benefit from vertebroplasty. The procedure can also be used in younger patients whose osteoporosis is caused by long-term steroid treatment or a metabolic disorder.


Vertebroplasty can increase the patient's functional abilities, allow a return to the previous level of activity, and prevent further vertebral collapse. Vertebroplasty attempts to also alleviate the pain caused by a compression fracture.


Vertebroplasty is often accomplished by injecting an orthopedic cement mixture through a needle into the fractured bone. The cement mixture can leak from the bone, potentially entering a dangerous location such as the spinal canal. The cement mixture, which is naturally viscous, is difficult to inject, through small diameter needles, and thus many practitioners choose to “thin out” the cement mixture to improve cement injection, which ultimately exacerbates the leakage problems. The flow of the cement liquid also naturally follows the path of least resistance once it enters the bone—naturally along the cracks formed during the compression fracture. This further exacerbates the leakage.


The mixture also fills or substantially fills the cavity of the compression fracture and is limited to certain chemical composition, thereby limiting the amount of otherwise beneficial compounds that can be added to the fracture zone to improve healing. In an alternative procedure known as kyphoplasty, a balloon is first inserted in the compression fracture and the vertebra and is expanded to create a void before the cement is injected into the newly formed space.


A vertebroplasty device and method that eliminates or reduces the risks and complexity of the existing art is desired. A vertebroplasty device and method that may reduce or eliminate the need to inject a liquid directly into the compression fracture zone is also desired.


Other ailments of the spine result in degeneration of the spinal disc in the intervertebral space between the vertebral bodies. These include degenerative disc disease and traumatic injuries. In either case, disc degeneration can cause pain and other complications. Conservative treatment can include non-operative treatment requiring patients to adjust their lifestyles and submit to pain relievers and a level of underlying pain. Operative treatment options include disc removal. This can relieve pain in the short term, but also often increases the risk of long-term problems and can result in motor and sensory deficiencies resulting from the surgery. Disc removal and more generally disc degeneration disease are likely to lead to a need for surgical treatment in subsequent years. The fusion or fixation will minimize or substantially eliminate relative motion between the fixed or fused vertebrae. In surgical treatments, adjacent vertebra can be fixated or fused to each other using devices or bone grafts. These may include, for example, screw and rod systems, interbody spacers (e.g., PEEK spacers or allograft bone grafts) threaded fusion cages and the like.


Some fixation or fusion devices are attached to the vertebra from the posterior side. The device will protrude and result in additional length (i.e., needed to overlap the vertebrae) and additional hardware to separately attach to each vertebrae. Fusion cages and allografts are contained within the intervertebral space, but must be inserted into the intervertebral space in the same dimensions as desired to occupy the intervertebral space. This requires that an opening sufficient to allow the cage or graft must be created through surrounding tissue to permit the cage or graft to be inserted into the intervertebral space.


A spinal fixation or fusion device that can be implanted with or without the need for additional hardware is desired. Also desired is a fixation or fusion device that can be deployed in a configuration where overlapping the fixated or fused vertebrae is not required.


Also desired is an intervertebral device the may be inserted in to the intervertebral space at a first smaller dimension and deployed to a second, larger dimension to occupy the intervertebral space. The ability to insert an intervertebral spacer at a dimension smaller than the deployed dimension would permit less disruption of soft and boney tissue in order to access the intervertebral space.


An effective therapy for following up a discectomy is desired. A vertebral fusion technique that can be used subsequent to a discectomy is desired.


SUMMARY OF THE INVENTION

An expandable support device that can be used to repair fractures and stabilize hard tissue, such as via intravertebral or intervertebral deployment, is disclosed. The expandable support device can have a longitudinal axis and a radial axis. The expandable support device can be configured, for example by design of the cells, voids or holes in the wall, to expand radially when compressed longitudinally. The expandable support device can be made from an integral piece of metal.


An expandable support device for performing completely implantable spinal repair is disclosed. The device has a first strut and a second strut attached to, and or integral with, the first strut. The first strut is substantially deformable. The second strut can be substantially inflexible.


The device can be configured to expand in a single direction. The device can be configured to expand in two directions.


The device can have a buttress. The buttress can have, for example, a coil, a wedge, and/or a hoop.


The device can have a locking pin. The locking pin can be interference fit with the device, for example with the first strut, and/or with a longitudinal port of the device.


Methods for deploying an expandable support device in the spine are disclosed. The expandable support device can be deployed, for example, by longitudinal compression. The longitudinal compression can result in radial expansion of the expandable support device. The expandable support device can be deployed in an intravertebral site. The expandable support device can be deployed in an intervertebral site.


Methods for repairing a damaged section of a spine are also disclosed. The methods include expanding an expandable support device in the damaged section. The expandable support device is loaded on a balloon during the expanding. Expanding includes inflating a balloon. Inflating the balloon includes inflating the balloon equal to or greater than about 5,000 kPa of internal pressure, or equal to or greater than about 10,000 kPa of internal pressure.


Tools for deploying an expandable support device are disclosed. The tools can be configured to apply a compressive force on the expandable support device along the expandable support device's longitudinal axis. The tools can be configured to securely engage the expandable support device. The tools can be configured to removably attach to opposing points at or near opposing longitudinal ends of the expandable support device. Actuation of the tool to apply a compressive force may include squeezing two handles together or rotating a knob or handle.


In all configurations and contemplated uses, the expandable device may be filled with a material suitable for the contemplated use. By way of example, when used to treat compression fractures, it is contemplated that a suitable material such bone cement, tissue or bone growth factors, bone morphogenic proteins, stem cells, carriers for any of the foregoing, or mixtures thereof may be inserted within the expandable device to provide support, fixation and/or improved bone structure. In the case of growth factors or stem cells, it is contemplated these may be obtained autologously, such as from the patient's own blood or bone marrow aspirate. By way of further example, when the device is used as an intervertebral spacer for fusion, it is contemplated that the expandable device may be filled with autograft, allograft, bone extenders (e.g., calcium phosphate or tricalcium phosphate or mixtures thereof or other similar materials), bone growth factors, bone morphogenic proteins, stem cells, carriers for any of the foregoing, and mixtures thereof. As contemplated above, growth factors and stem cells may be commercially available or may be extracted from the patient's own blood or bone marrow aspirate.


In addition, it is contemplated that the ratio of the expansion for the expandable devices (the ratio of the unexpanded height or diameter, depending on configuration, to the expanded height or diameter) may be from 1:2 to 1:5 or greater. For intravertebral and intervertebral applications applicants have found that expansion ratios of from about 1:3 to about 1:4 are acceptable. For vertebroplasty or interbody applications it is contemplated that a device having an initial height or diameter from about 4 mm (0.16 in.) to about 8 mm (0.31 in.) and an expanded height or diameter from about 7 mm (0.28 in.) to about 18 mm (0.71 in.) may be desirable.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1 through 3 are side perspective views of various variations of the expandable support device.



FIGS. 4 through 6 illustrate various variations of cross-section A-A of the expandable support device.



FIG. 7 through 10 are side perspective views of various variations of the expandable support device.



FIG. 11 is a side perspective view of a variation of the expandable support device in a contracted configuration.



FIGS. 12 through 14 illustrate a variation of a method of deploying multiple expandable support devices.



FIG. 15 is a schematic figure of a variation of the expandable support device in a contracted configuration.



FIG. 16 is a schematic figure of a variation of the expandable support device of FIG. 15 in an expanded configuration.



FIG. 17 is a perspective view of a variation of the expandable support device.



FIG. 18 is a side view of the variation of the expandable support device of FIG. 17.



FIG. 19 is a top view of the variation of the expandable support device of FIG. 17.



FIG. 20 is a front view of the variation of the expandable support device of FIG. 17.



FIG. 21 is a perspective view of a variation of the expandable support device.



FIG. 22 is a side view of the variation of the expandable support device of FIG. 21.



FIG. 23 is a front view of the variation of the expandable support device of FIG. 21.



FIG. 24 is a perspective view of a variation of the expandable support device.



FIG. 25 is a front view of the variation of the expandable support device of FIG. 24.



FIG. 26 illustrates a flattened pattern for a variation of the expandable support device.



FIG. 27 is a perspective view of a variation of the expandable support device.



FIG. 28 is a front view of the variation of the expandable support device of FIG. 27.



FIG. 29 is a perspective view of a variation of the expandable support device.



FIG. 30 is a front view of the variation of the expandable support device of FIG. 29.



FIG. 31 is a perspective view of a variation of the expandable support device.



FIG. 32 is top view of the variation of the expandable support device of FIG. 31.



FIG. 33 is a side view of the variation of the expandable support device of FIG. 31.



FIG. 34 is a front view of the variation of the expandable support device of FIG. 31.



FIG. 35 illustrates a variation of section A-A of the variation of the expandable support device of FIG. 31.



FIG. 36 illustrates a variation of section B-B of the variation of the expandable support device of FIG. 31.



FIG. 37 is a side perspective view of a variation of the expandable support device.



FIG. 38 is a front view of the variation of the expandable support device of FIG. 37.



FIG. 39 is a rear perspective view of the variation of the expandable support device of FIG. 37.



FIG. 40 is a bottom view of the variation of the expandable support device of FIG. 37.



FIG. 41 is a side view of the variation of the expandable support device of FIG. 37.



FIGS. 42 and 43 are side views of various variations of the expandable support device.



FIG. 44 is a side perspective view of a variation of the expandable support device.



FIGS. 45 through 47 are front views of various variations of the expandable support devices.



FIG. 48 is a top perspective view of a variation of the expandable support device.



FIG. 49 is top view of the variation of the expandable support device of FIG. 48.



FIG. 50 is a front view of the variation of the expandable support device of FIG. 48.



FIGS. 51 and 52 illustrate a variation of a method for using a delivery system for the expandable support element.



FIGS. 53 through 55 illustrate a variation of a method for accessing a damage site in the vertebra.



FIG. 56 illustrates two methods for delivering expandable support devices to the vertebral column.



FIGS. 57 through 62 illustrate various methods for deploying the expandable support device into the damage site in the vertebra.



FIGS. 63 and 64 illustrate a variation of a method for deploying one or more expandable support devices into one or more damage sites in the vertebra.



FIG. 65 illustrates a variation of a method for deploying the expandable support device into the damage site in the vertebra.



FIG. 66 illustrates a variation of a method for deploying the expandable support device into the damage site in the vertebra.



FIG. 67 illustrates variations of methods for deploying the expandable support device into the damage site in the vertebra.



FIGS. 68 and 69 illustrate a variation of a method for deploying the expandable support device into the damage site in the vertebra.



FIGS. 70 and 71 illustrate a variation of a method for deploying a locking pin into the expandable support device in the damage site in the vertebra.



FIGS. 72 through 77 illustrate a variation of a method for deploying a locking pin into the expandable support device.



FIG. 78 illustrates a variation of the slidable expansion device.



FIG. 79 illustrates a variation of a method for loading the expandable support device of FIG. 10 onto the slidable expansion device of FIG. 78.



FIGS. 80 and 81 illustrate a variation of a method for using the slidable expansion device.



FIG. 82 illustrates a variation of a method for using the slidable expansion device.



FIG. 83 illustrates a variation of a method for using the slidable expansion device.



FIGS. 84 and 85 show side and front views, respectively, of a variation of the expansion component.



FIGS. 86 and 87 show side and front views, respectively, of a variation of a method for using the variation of the expansion component of FIGS. 84 and 85.



FIGS. 88 and 89 show side and front views, respectively, of a variation of the expansion component.



FIGS. 90 and 91 show side and front views, respectively, of a variation of a method for using the variation of the expansion component of FIGS. 88 and 89.



FIGS. 92 and 93 show side and front views, respectively, of a variation of the expansion component.



FIGS. 94 and 95 show side and front views, respectively, of a variation of a method for using the variation of the expansion component of FIGS. 92 and 93.



FIGS. 96 and 97 show side and front views, respectively, of a variation of the expansion component.



FIGS. 98 and 99 show side and front views, respectively, of a variation of a method for using the variation of the expansion component of FIGS. 96 and 97.



FIGS. 100 and 101 show side and front views, respectively, of a variation of the expansion component.



FIGS. 102 and 103 show side and front views, respectively, of a variation of a method for using the variation of the expansion component of FIGS. 100 and 101.



FIGS. 104 and 105 illustrate a variation of the expansion component and a variation of a method for using the expansion component.



FIGS. 106 and 107 illustrate a variation of a deployment tool.



FIGS. 108 through 110 illustrate a variation of a method of expanding the expandable support device using the deployment tool of FIGS. 106 and 107.



FIGS. 111 and 112 are schematic illustrations of the forces acting on the expandable support device as illustrated in FIGS. 108-110.



FIGS. 113 and 114 illustrate a variation of the expandable support device in an expanded configuration.



FIGS. 115 and 116 illustrate a variation of a method for deploying the expandable support device into the damage site in the vertebra.



FIG. 117 illustrates a variation of a method for deploying a second expandable support device or locking pin in the damage site in the vertebra.



FIGS. 118 through 120 illustrate a method for deploying a second expandable support device in the vertebra.



FIG. 121 is a close-up view of a variation of section A-A of FIG. 120.



FIG. 122 illustrates a variation of a buttress.



FIGS. 123 through 125 illustrate variations of section B-B of the buttress of FIG. 122.



FIGS. 126 through 128 illustrate a variation of a method for deploying a buttress.



FIG. 129 illustrates a variation of a method for deploying a buttress.



FIGS. 130 through 132 illustrate a variation of a method for deploying a buttress



FIG. 133 illustrates a variation of a buttress.



FIG. 134 illustrates a variation of section C-C of the buttress of FIG. 133.



FIG. 135 illustrates a variation of a method for deploying a buttress.



FIGS. 136 through 139 illustrate a method for deploying the expandable support device of FIGS. 17 through 20.



FIGS. 140 through 142 illustrate a method for deploying the expandable support device of FIGS. 31 through 34.



FIG. 143 illustrates the deployed expandable support device of FIGS. 31 through 34 in use.



FIGS. 144 and 145 illustrate a method for deploying the expandable support device of FIGS. 35 and 36.



FIG. 146 illustrates a method of using the expandable support device of FIGS. 31 through 34 with the band.



FIG. 147 through 149 illustrate variations of a locking pin.





DETAILED DESCRIPTION


FIG. 1 illustrates an expandable support device 2, such as a stent, that can be implanted in a bone, such as a compression fracture in a vertebra, in the intervertebral space between two vertebrae, or in soft tissue, such as a herniated intervertebral disc. The expandable support device 2 should be biocompatible. The expandable support device 2 can have one of many configurations, and can be used, for example, for methods of repairing vertebral bone fractures or supporting adjacent vertebral bodies for fusion. The expandable support device 2 can have a first end 4 and a second end 6.



FIG. 2 illustrates that the expandable support device 2 can have a wall 8. The wall 8 can have struts 10. The struts 10 can in density along the length of the expandable support device 2 from the first end 4 to the second end 6. The density of the struts 10 can be higher near the first end 4 than near the second end 6 (as shown). The density of the struts 10 can be higher near the second end 6 than near the first end 4. The density of the struts 10 can be higher near the first end 4 and the second end 6 than the middle between the first 4 and second ends 6. Controlling the density, thickness and arrangement of the struts results in controlled deployment and shape of the implant.



FIG. 3 illustrates that the expandable support device 2 can have a tapered configuration before or after deployment. The first end 4 can have a first diameter 12. The second end 6 can have a second diameter 14. The second diameter 14 can be greater than the first diameter 12 (as shown). The first diameter 12 can be greater than the second diameter 14. The first diameter 12 and second diameters 14 can both be greater than a diameter in the middle of the expandable support device 2 between the first end 4 and second end 6. The tapered configuration can be a result of a greater strength of the expandable support device 2 at or near the tapered section or end of the expandable support device 2. A greater density of struts 10 can be at the first end 4 to achieve this result. The struts 10 at the first end 4 can have a greater strut diameter than the struts 10 at the second end 6. The expandable support device 2 can have a first port 16 at the first end 4. The expandable support device 2 can have a second port 18 at the second end 6.



FIG. 4 illustrates that the device in cross-section A-A can have a varying watt thickness 20 along a longitudinal length of the expandable support device 2 from the first end 4 to the second end 6. The wall thickness 20 can be greater at the first 4 and second ends 6 than in the middle of the expandable support device 2 between the first 4 and second ends 6.



FIG. 5 illustrates that the wall 8 can be made from struts 10. The strut diameters 22 can vary along the length of the expandable support device 2. FIG. 5 illustrates the strut diameters 22 can be greater at the first 4 and second ends 6 than the strut diameters 22 between the first 4 and second ends 6. FIG. 6 illustrates that the strut diameters 22 can be greater at the second end 6 than the strut diameters 22 at the first end 4. The strength of the wall 8 can be adjusted along the length of the expandable support device 2 by designing varying, for example, strut diameters 22, strut cross-sectional areas, strut densities (i.e., strut spacing, number of struts), strut cross-sectional geometries, and combinations thereof.



FIG. 7 illustrates that the expandable support device 2 can have a bullet shape. The wall 8 can have a first radius of curvature 24 near or at the first end 4. The first end 4 can have a first rim 26 circumferentially around the first end 4. The wall 8 can have a second radius of curvature 28 near or at the second end 6. The first radius of curvature 24 can be less than the second radius of curvature 28 (as shown). The first radius of curvature 24 can be greater than the second radius of curvature 28. The first and second radii of curvature can be greater than a radius of curvature between the first 4 and second ends 6.



FIG. 8 illustrates that the expandable support device 2 can be sharply pointed at the first end 4 (as shown), and/or second end 6. The first end 4 can have a smaller first port 16 than the second port 18, or no first port 16 (as shown). The first end 4 can be made from, for example, a plastic and/or dense mesh of thick wires.



FIG. 9 illustrates that the expandable support device 2 can have a thread 34. The expandable support device 2 can be rotated during implantation to screw into an implant site, such as a vertebra.



FIG. 10 illustrates an expandable support device 2 that can have an engagement groove 36. The engagement groove 36 can be on the inner diameter of the expandable support device 2. The engagement groove 36 can be configured to engage the external engagement thread on the expansion component.



FIG. 11 illustrates a twistable coil variation of the expandable support device 2 in an untwisted configuration. The untwisted expandable support device 2 can have a contracted diameter 38. The contracted diameter 38 can be less than the expanded diameter of the twistable coil variation of the expandable support device 2. The coils can be resiliently or deformably altered in configuration during untwisting. The coils can resiliently expand when released from the untwisted configuration.



FIG. 12 illustrates that multiple expandable support devices 2 can each have an outer diameter and an inner diameter in a relaxed configuration. The first expandable support device 40 can have a first device outer diameter 42 that can be equal to or greater, for example by a substantially small amount, than a second device inner diameter 44. The second expandable support device 46 can have a second device outer diameter 48 that can be equal to or greater, for example by a substantially small amount, than a third device inner diameter 50. The first device 40 can have a first device inner diameter 52 and the third device 54 can have a third device outer diameter 56.


As shown in FIGS. 12 and 13, the third expandable support device 54 can be deployed. The second expandable support device 46 can then be inserted 58 into the third expandable support device 54. The second expandable support device 46 can then be expanded 60 in the third expandable support device 54.


As shown in FIGS. 12 and 14, the first expandable support device 40 can then be inserted 62 into the second expandable support device 46. The first expandable support device 40 can then be expanded 64 into the second expandable support device 46. The concentrically smaller expandable support devices 2 can butt against the next larger expandable support devices 2 (the gap shown in FIG. 14 between the third and second expandable support devices 54 and 46, respectively, is for illustrative purposes). As shown in greater detail below, each expandable support device 2 can support, and/or substantially lock into place, the next larger, abutting, expandable support device 2.



FIGS. 15 and 16 illustrate an expandable support device 2 that can have a first wedge 66 and a second wedge 68, such as the buttress of FIGS. 133 through 135, supra, of which any characteristic, feature, or functionality can be used for the expandable support device 2 described herein. A first wedge force 70 can be applied to the first wedge 66. A second wedge force 72 can be applied to the second wedge 68. The first wedge 66 can translate in the direction of arrow 74, as shown. The second wedge 68 can translate in the direction of arrow 76, as shown. FIG. 16 illustrates that the expandable support device 2 can have a larger, expanded diameter 78 after the first 70 and second wedge forces 72 have been applied.



FIGS. 17 through 20 illustrate a variation of a biocompatible implant that can be used for tissue repair, for example for repair bone fractures such as spinal compression fractures, and/or repairing soft tissue damage, such as herniated vertebral discs and/or an intervertebral/interspinous spacer or fusion device. The implant can be an expandable support device 2, for example a stent. The expandable support device 2 can have a longitudinal axis 80. The expandable support device 2 can have an elongated wall 8 around the longitudinal axis 80. The expandable support device 2 can have a substantially and/or completely hollow longitudinal port 82 along the longitudinal axis 80.


The wall 8 can have one or more first struts 84. The first struts 84 can be configured to be deformable and/or expandable. The wall 8 can have can have one or more second struts 86. The second struts 86 can be substantially undeformable and substantially inflexible. The first struts 84 can be flexibly (e.g., deformably rotatably) attached to the second struts 86.


The wall 8 can be configured to expand radially away from the longitudinal axis 80, for example in two opposite radial directions. A first set of first struts 84 can be aligned parallel to each other with respect to the longitudinal axis 80. A second set of first struts 80 can be aligned parallel to each other with respect to the longitudinal axis 80. The second set of first struts 84 can be on the opposite side of the longitudinal axis 80 from the first set of first struts 84. The second struts 86 can attach any or all sets of first struts 84 to other sets of first struts 84.


The second struts 86 can have one or more ingrowth ports 88. The ingrowth ports 88 can be configured to encourage biological tissue ingrowth therethrough during use in order to aid in fixing the expandable support device in place and/or promote fusion of adjacent bone structures, either within the same bone (e.g., for vertebroplasty or kyphoplasty) or between adjacent bone structures (e.g., between adjacent vertebral bodies to promote fusion). The ingrowth ports 88 can be configured to releasably and/or fixedly attach to a deployment tool or other tool. The ingrowth ports 88 can be configured to increase, and/or decrease, and/or focus pressure against the surrounding biological tissue during use. The ingrowth ports 88 can be configured to increase and/or decrease the stiffness of the second struts 86. The ingrowth ports 88 can be configured to receive and/or attach to a buttress.


The first struts 84 can be configured to have a “V” shape. The space between adjacent first struts 84 can be configured to receive and/or attach to a locking pin during use.


The wall 8 can have a wall thickness 20. The wall thickness 20 can be from about 0.25 mm (0.098 in.) to about 5 mm (0.2 in.), for example about 1 mm (0.04 in.). The wall 8 can have an inner diameter 90. The inner diameter 90 can be from about 1 mm (0.04 in.) to about 30 mm (1.2 in.), for example about 6 mm (0.2 in.). The wall thickness 20 and/or the inner diameter 90 can vary with respect to the length along the longitudinal axis 80. The wall thickness 20 and/or the inner diameter 90 can vary with respect to the angle formed with a plane parallel to the longitudinal axis 80. The expandable support device may have an expansion ratio (i.e., the ratio of the unexpanded diameter to the expanded diameter) of from about 1:2 to about 1:5 or greater, depending upon the application. For vertebroplasty and intervertebral spacing the expansion ratio is preferably about 1:3 to about 1:4.



FIGS. 21 through 23 illustrate another variation of an expandable support device 2 that can be configured to expand away from the longitudinal axis 80 in more than two opposite directions, for example in two sets of opposite radial directions. The wall 8 can have four sets of first struts 84. Each set of first struts 84 can be opposite to another set of first struts 84. Each of four sets of second struts 86 can attach each set of first struts 84. Providing four orthogonally oriented sets of first struts 10 permits expansion in two orthogonal planes, which advantageously may be considered height and width directions. In the case of an intervertebral implant, for example, such expansion in two directions permits height expansion to engage and support adjacent vertebral bodies and width expansion to increase the width of the surface contact area or “footprint” of engagement between the implant and the adjacent vertebrae. The implant may be filled with bone growth promoting substances (e.g., autologous bone, allograft bone, bone extenders, bone growth factors, bone morphogenic proteins, stem cells, carriers for any of them, and mixtures of any of them or with other suitable substances) to promote bone growth into and through the space.


The first struts 84 on a first longitudinal half of the expandable support device 2 can be oriented (e.g., the direction of the pointed end of the “V” shape) in the opposite direction as the first struts 84 on a second longitudinal half of the expandable support device 2. See FIGS. 21-22. Orienting the first struts 84 in opposite directions permits controlled expansion of the expandable support device 2 such that the overall length of the expandable support device 2 can be conserved during and after expansion, with minimal longitudinal displacement of radially opposed sides of the expandable support device 2.



FIGS. 24 and 25 illustrate that the longitudinal port 82 can have one or more lock grooves 92. The lock grooves 92 can be configured to receive and/or slidably and fixedly or releasably attach to a locking pin or buttress. As explained in greater detail below, the locking pin or buttress may be an insertable structure separate from the expandable support device 2 or may be preassembled to the expandable support device 2 or may be integrally formed with the expandable support device 2.



FIG. 26 illustrates a visually flattened pattern of the wall 8 for another variation of the expandable support device 2. (The pattern of the wall 8 can be flattened for illustrative purposes only, or the wall 8 can be cut in a flattened state and welded or otherwise secured into a three dimensional shape during the manufacturing process.) The pattern can have multiple configurations for the first and/or second struts 84 and/or 86. For example, first struts 84 can have a first configuration 84a (e.g., a “V” shape in oppositely oriented sets) and first struts 84 can have a second configuration 84b (e.g., a “U” shape in oppositely oriented sets. In FIG. 26, second struts 12 are relatively narrow between the sets of first struts).



FIGS. 27 and 28 illustrate that that rather than the generally circular or oval cross sectional shape of prior variations, the expandable support device 2 can have a square or, rectangular cross-sectional configuration. As shown, the square or rectangular configuration can include features such as grooves 20 to receive one or more locking pins or buttresses, as contemplated herein.



FIGS. 29 and 30 illustrate that the expandable support device 2 can have protruding tissue engagement elements, such as tissue hooks, and/or barbs, and/or cleats 94 (referred to herein as cleats 94). The cleats 94 can be integral with and/or fixedly or removably attached to the first and/or second struts 86. The cleats 94 can be on substantially opposite sides of the expandable support device 2. As will be appreciated, as the expandable support device 2 can be expanded the tissue engagement elements will engage adjacent tissue, e.g., adjacent vertebral bodies in the case of an intervertebral spacer, to help secure the device in place relative to adjacent structures.



FIGS. 31 through 34 illustrate that the expandable support device 2 can have panels attached to other panels at flexible joints. The expandable support device 2 can have first panels 96 attached to and/or integral with second panels 98 at first joints 100. The second panels 98 can be attached to and/or integral with third panels 102 at second joints 104. The expandable support device 2 can have one or more tool engagement ports 106, for example on the first panels 96. The expandable support device 2 can have one or more ingrowth ports 88, for example, on the third panels 102. The outside of the first panel 96 can be concave.



FIGS. 35 and 36 illustrate that the expandable support device 2 can have first and/or second struts 84, 86 and/or and panels 96, 98. The first and/or second struts 84, 86 can be internal to the panels 96, 98. The first struts 84 can be attached to the third panels 102.


The expandable support device 2 can have a radius of curvature along the longitudinal axis 80. The radius of curvature can be from about 1 mm (0.04 in.) to about 250 mm (10 in.), for example about 50 mm (2 in.). (The wall 8 is shown sans panels or struts for illustrative purposes.) The expandable support device 2 can have at least one flat side, for example two flat sides. The two flat sides can be on opposite sides of the expandable support device 2 from each other. In the variation shown in FIGS. 35-36, the internal first strut 84 can help provide controlled expansion of the device and internal support to the expanded device.



FIGS. 37 through 41 illustrate an expandable support device 2, that can be implanted in a bone, such as a compression fracture in a vertebra, or in soft tissue, such as a herniated intervertebral disc, or interspinous ligament. The expandable support device 2 should be biocompatible. The expandable support device 2 can be used for tissue repair, for example for repair bone fractures such as spinal compression fractures, and/or repairing soft tissue damage, such as herniated vertebral discs of fusion or fixation.


The expandable support device 2 can have a longitudinal axis 80. The expandable support device 2 can have a first end 4 and a second end 6. The first end 4 can be substantially parallel with the second end 6. The first end 4 may be displaced from the longitudinal axis 80 by a first angle 108 and the second end may be displaced from the longitudinal axis 80 by a second angle 110 when the expandable support device 2 is in a contracted configuration (as shown). The expandable support device 2 can be hollow, for example along the longitudinal axis 80. The first end 4 can have a first port 16. The second end 6 can have a second port 18. The first angle 108 can be substantially equal to the second angle 110. The angles 108, 110 can be from about 0° to about 90°, more narrowly from about 5° to about 45°, yet more narrowly from about 10° to about 30°, for example about 20°.


The expandable support device 2 can have a wall 8. The outer and/or inner surfaces of the wall 8 can be configured to increase friction or be capable of an interference fit with another object, such as a second expandable support device 46. The configurations to increase friction or be capable of an interference fit include teeth, knurling, coating, or combinations thereof.


The wall 8 can have struts 10. By way of example only, the wall 8 can have about 8 struts 10 on each side of the expandable support device 2, The struts 10 can be substantially parallel to the slanted configuration of the angled first end 4 and/or second end 6. The struts 10 can be separated from the other struts 10 by wall openings 112. The expandable support device 2 can have about 7 wall openings 112 on each side. The wall openings 112 can be substantially parallel to the first end 4 and/or second end 6, for example when the expandable support device 2 is in a contracted configuration. The expandable support device 2 can have ingrowth ports 88.


The expandable support device 2 can have a first port 16 and/or a second port 18. A hollow of the expandable support device 2 can be completely or partially coated and/or filled with agents and/or a matrix as listed below.


The leading end of the expandable support device 2 can be sharpened. The leading end can be used to help move tissue aside during implantation and deployment. The leading end can be self-penetrating.


When in a contracted configuration, the expandable support device 2 can have a contracted length 114 (i.e., the length when the expandable support device is in a radially contracted configuration) and a contracted height 116. By way of example only, the contracted length 114 can be from about 0.318 cm (0.125 in.) to about 10 cm (4 in.), for example about 3.8 cm (1.5 in). The contracted height 116 can be from about 0.1 cm (0.05 in.) to about 3 cm (1 in.), for example about 0.8 cm (0.3 in.).



FIG. 42 illustrates that the expandable support device 2 can have shorter struts 10 than the struts shown in FIGS. 37 through 41. By the way of example only, the length of the struts 10 can be from about 0.3 cm (0.1 in.) to about 5 cm (2 in.), for example about 2 cm (0.7 in.), also for example about 1 cm (0.5 in.).



FIG. 43 illustrates that the expandable support device 2 can have from relatively few struts 10. It is contemplated that the expandable support device 2 may have from about 2 struts to about 50 struts 10. About 4 struts 10 to about 8 struts 10 may be suitable for many applications. The expandable support device 2 can have from about 1 wall opening 112 to about 51 wall openings 112, for example about 3 wall openings 112, also for example about 7 wall openings 112.



FIG. 44 illustrates that the expandable support device 2 can have a first pane 118, a second pane 120, a third pane 122, and a fourth pane 124. A first joint 100 can attach the first pane 118 to the second pane 120. A second joint 104 can attach the second pane 120 to the third pane 122. A third joint 126 can attach the third pane 122 to the fourth pane 124. The joints can rotatably attach the panes. The joints can be separate from or integral with the panes. Each pane can have struts 10 and wall openings 112. During use, the joints can enable the panes to rotate in-plane, as shown by arrows 128.



FIGS. 45, 46 and 47 illustrate that the expandable support device 2, can have for example a square or rectangular, circular, or polygonal cross-section, respectively. FIG. 47 shows the joints as contemplated above in the description of FIG. 44 as nodes having a wider section than the wall 8, but the joints can also have the same width or a smaller width than the wall 8.



FIGS. 48 through 50 illustrate that the expandable support device 2 can have a radius of curvature 130 along the longitudinal axis 80. The radius of curvature 130 can be from about 1 mm (0.04 in.) to about 250 mm (10 in.), for example about 50 mm (2 in.). The wall 8 is shown without panels or struts 10 for illustrative purposes, but it will be understood that the initial configuration and deployment force and method can influence the shape of the deployed implant. The expandable support device 2 can have at least one flat side, for example two flat sides. The two flat sides can be on opposite sides of the expandable support device 2 from each other.


The expandable support devices 2 can have textured and/or porous surfaces for example, to increase friction against bone surfaces, and/or promote tissue ingrowth. The expandable support devices 2 can be coated with a bone growth factor, such as a calcium base.


The expandable support device 2 can be covered by a thin metal screen. The thin metal screen can expand and/or open when the expandable support device 2 expands.


Any or all elements of the expandable support device 2 and/or other devices or apparatuses described herein can be made from, for example, a single or multiple stainless steel alloys, nickel titanium alloys (e.g., Nitinol), cobalt-chrome alloys (e.g., ELGILOY®) from Elgin Specialty Metals, Elgin, Ill.; CONICHROME® from Carpenter Metals Corp., Wyomissing, Pa.), nickel-cobalt alloys (e.g., MP35N® from Magellan Industrial Trading Company, Inc., Westport, Conn.), molybdenum alloys (e.g., molybdenum TZM alloy, for example as disclosed in International Pub. No. WO 03/082363 A2, published 9 Oct. 2003, which is herein incorporated by reference in its entirety), tungsten-rhenium alloys, for example, as disclosed in International Pub. No. WO 03/082363, polymers such as polyethylene teraphathalate (PET)/polyester (e.g., DACRON® from Du Pont de Nemours and Company, Wilmington, Del.), polypropylene, (PET), polytetrafluoroethylene (PTFE), expanded PTFE (ePTFE), polyether ketone (PEK), polyether ether ketone (PEEK), poly ether ketone ketone (PEKK) (also poly aryl ether ketone ketone), nylon, polyether-block co-polyamide polymers (e.g., PEBAX® from ATOFINA, Paris, France), aliphatic polyether polyurethanes (e.g., TECOFLEX® from Thermedics Polymer Products, Wilmington, Mass.), polyvinyl chloride (PVC), polyurethane, thermoplastic, fluorinated ethylene propylene (FEP), absorbable or resorbable polymers such as polyglycolic acid (PGA), polylactic acid (PLA), polycaprolactone (PCL), polyethyl acrylate (PEA), polydioxanone (PDS), and pseudo-polyamino tyrosine-based acids, extruded collagen, silicone, zinc, echogenic, radioactive, radiopaque materials, a biomaterial (e.g., cadaver tissue, collagen, allograft, autograft, xenograft, bone cement, morselized bone, osteogenic powder, beads of bone) any of the other materials listed herein or combinations thereof. Examples of radiopaque materials are barium sulfate, zinc oxide, titanium, stainless steel, nickel-titanium alloys, tantalum and gold.


Any or all elements of the expandable support device 2 and/or other devices or apparatuses described herein, can be, have, and/or be completely or partially coated with agents and/or a matrix a matrix for cell ingrowth or used with a fabric, for example a covering (not shown) that acts as a matrix for cell ingrowth. The matrix and/or fabric can be, for example, polyester (e.g., DACRON® from E. I. Du Pont de Nemours and Company, Wilmington, Del.), polypropylene, PTFE, ePTFE, nylon, extruded collagen, silicone or combinations thereof.


The expandable support device 2 and/or elements of the expandable support device 2 and/or other devices or apparatuses described herein and/or the fabric can be filled, coated, layered and/or otherwise made with and/or from cements, fillers, glues, and/or an agent delivery matrix known to one having ordinary skill in the art and/or a therapeutic and/or diagnostic agent. Any of these cements and/or fillers and/or glues can be osteogenic and osteoinductive growth factors.


Examples of such cements and/or fillers includes bone chips, demineralized bone matrix (DBM), calcium sulfate, coralline hydroxyapatite, biocorat, tricalcium phosphate, calcium phosphate, polymethyl methacrylate (PMMA), biodegradable ceramics, bioactive glasses, hyaluronic acid, lactoferrin, bone morphogenic proteins (BMPs) such as recombinant human bone morphogenetic proteins (rhBMPs), other materials described herein, or combinations thereof.


The agents within these matrices can include any agent disclosed herein or combinations thereof, including radioactive materials; radiopaque materials; cytogenic agents; cytotoxic agents; cytostatic agents; thrombogenic agents, for example polyurethane, cellulose acetate polymer mixed with bismuth trioxide, and ethylene vinyl alcohol; lubricious, hydrophilic materials; phosphor cholene; anti-inflammatory agents, for example non-steroidal anti-inflammatories (NSAIDs) such as cyclooxygenase-1 (COX-1) inhibitors (e.g., acetylsalicylic acid, for example ASPIRIN® from Bayer AG, Leverkusen, Germany; ibuprofen, for example ADVIL® from Wyeth, Collegeville, Pa.; indomethacin; mefenamic acid), COX-2 inhibitors (e.g., VIOXX® from Merck & Co., Inc., Whitehouse Station, N.J.; CELEBREX® from Pharmacia Corp., Peapack, N.J.; COX-1 inhibitors); immunosuppressive agents, for example Sirolimus (RAPAMUNE®, from Wyeth, Collegeville, Pa.), or matrix metalloproteinase (MMP) inhibitors tetracycline and tetracycline derivatives) that act early within the pathways of an inflammatory response. Examples of other agents are provided in Walton et al, Inhibition of Prostoglandin E2 Synthesis in Abdominal Aortic Aneurysms, Circulation, Jul. 6, 1999, 48-54; Tambiah et al, Provocation of Experimental Aortic Inflammation Mediators and Chlamydia Pneumoniae, Brit. J. Surgery 88 (7), 935-940; Franklin et al, Uptake of Tetracycline by Aortic Aneurysm Wall and Its Effect on Inflammation and Proteolysis, Brit. J. Surgery 86 (6), 771-775; Xu et al, Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium, J. Biological Chemistry 275 (32) 24583-24589; and Pyo et al, Targeted Gene Disruption of Matrix Metalloproteinase-9 (Gelatinase B) Suppresses Development of Experimental Abdominal Aortic Aneurysms, J. Clinical Investigation 105 (11), 1641-1649 which are all incorporated by reference in their entireties.


The expandable support devices 2 can be laser cut, machined, cut by wire electrical discharge machining (“EDM”) or made by other suitable techniques. The expandable support device 2 can be cut in a fully contracted or unexpanded configuration or may be cut in a partially opened pattern, then loaded (e.g., crimped) onto a deployment tool 132 (e.g., balloon 134). The loaded expandable support device 2 can have a smaller profile while plastically deforming the struts 10 past their limits.


The expandable support device 2 can be longitudinally segmented. Multiple expandable support devices 2 can be attached first end 4 to second end 6, and/or a single expandable support device 2 can be severed longitudinally into multiple expandable support devices 2.


Method of Use


FIG. 51 illustrates that the expandable support device 2 can be loaded in a collapsed (i.e., contracted) configuration onto a deployment tool 132. The deployment tool 132 can have an expandable balloon 134 catheter 136 as known to those having an ordinary level of skill in the art. The catheter 136 can have a fluid conduit 138. The fluid conduit 138 can be in fluid communication with balloon 134. The balloon 134 and the deployment tool 132 can be the balloon 134 and deployment tool 132 described in PCT Application No. US2005/033,965, Publication No. WO 2006/034,396, filed 21 Sep. 2005 entitled “Balloon and Methods of Making and Using.” The balloon 134 can be configured to receive a fluid pressure of at least about 5,000 kPa (50 atm), more narrowly at least about 10,000 kPa (100 atm), for example at least about 14,000 kPa (140 atm).


Alternatively, the deployment tool 132 can be a pair of wedges, an expandable jack, other expansion tools, or combinations thereof.



FIG. 52 illustrates that the fluid pressure in the fluid conduit 138 and balloon 134 can increase, thereby inflating the balloon 134, as shown by arrows. The expandable support device 2 can expand, for example, due to pressure from the balloon 134.



FIG. 53 (side view) and 54 (top view) illustrate a vertebral column 140 that can have one or more vertebra 142 separated from the other vertebra 142 by discs 144. The vertebra 142 can have a damage site 146, for example a compression fracture.


An access tool 148 can be used to gain access to the damage site 146 and or increase the size of the damage site 146 to allow deployment of the expandable support device 2. The access tool 148 can be a rotating or vibrating drill 150 that can have a handle 152. Optionally, the drill 150 may oscillate, as shown by arrows 154. The drill 150 can then be translated, as shown by arrow 156, toward and into the vertebra 142 so as to pass into the damage site 146.



FIG. 55 illustrates that the access tool 148 can be translated, as shown by arrow 158, to remove tissue at the damage site 146. The access tool 148 can create an access port 160 at the surface of the vertebra 142. The access port 160 can open to the damage site 146. The access tool 148 can then be removed from the vertebra 142.



FIG. 56 illustrates that a first deployment tool 162 can enter posteriorly through the subject's back. The first deployment tool 162 can enter through a first incision 164 in the skin 166 on the posterior side 167 of the subject near the vertebral column 140. The first deployment tool 162 can be translated, as shown by arrow 168, to position a first expandable support device 40 into a first damage site 170. The first access port 172 can be on the posterior side 167 of the vertebra 142.


A second deployment tool 174 can enter through a second incision 176 (as shown) in the skin 166. The second incision 176 may be posterior (as shown) or may be anterior, lateral, posterior lateral, or the like. The second deployment tool 174 can be translated through muscle (not shown), around nerves 178, the spinal cord 180, and anterior 182 of the vertebral column 140. The second deployment tool 174 can be steerable. The second deployment tool 174 can be steered, as shown by arrow 184, to align the distal tip of the second expandable support device 46 with a second access port 186 on a second damage site 188. The second access port 186 can face anteriorly 182. The second deployment tool 174 can translate, as shown by arrow 190, to position the second expandable support device 46 in the second damage site 188.


As illustrated, the vertebra 142 can have multiple damage sites and expandable support devices deployed therein. The expandable support devices can be deployed from the anterior 182, posterior 167, both lateral, superior, inferior, any angle, or combinations of the directions thereof. Of course, a single device may be deployed from one direction rather than multiple devices from multiple directions.



FIGS. 57 and 58 illustrate translating, as shown by arrow, the deployment tool 132 loaded with the expandable support device 2 through the access port 160 from the anterior side 182 of the vertebral column 140. FIGS. 59 and 60 illustrate that the deployment tool 132 can be deployed from the posterior side 167 of the vertebral column 140. The deployment tool 132 can be deployed off-center, for example, when approaching the posterior side 167 of the vertebral column 140.



FIG. 61 illustrates that deployment tool 132 can position the expandable support device 2 in the vertebra 142 and into the damage site 146.



FIG. 62 illustrates that the fluid pressure in the fluid conduit 136 and the balloon 134 can increase, thereby inflating the balloon 134, as shown by arrows. The expandable support device 2 can expand, for example, due to pressure from the balloon 134. The balloon 134 can be expanded until the expandable support device 2 is substantially fixed to the vertebra 142. The balloon 134 and/or the expandable support device 2 can reshape the vertebral column 140 to a more natural configuration during expansion of the device.



FIGS. 63 and 64 illustrate that first and second deployment tools 162 and 174 can position and deploy first and second expandable support devices 40 and 46 simultaneously, and/or in the same vertebra 142 and into the same or different damage sites 170 and 188.



FIG. 65 illustrates that the fluid pressure in the fluid conduit 138 and the balloon 134 can increase, thereby inflating the balloon 134, as shown by arrows. The expandable support device 2 can expand, for example, due to pressure from the balloon 134. The balloon 134 can be expanded until the expandable support device 2 is substantially fixed to the vertebra 142. The balloon 134 and/or the expandable support device 2 can reshape the vertebral column 140 to a more natural configuration during expansion of the balloon 134.



FIG. 66 illustrates that the access port 160 can be made close to the disc 144, for example when the damage site 146 is close to the disc 144. The deployment tool 132 can be inserted through the access port 160 and the expandable support device 2 can be deployed as described supra.



FIG. 67, a front view of the vertebral column 140, illustrates that more than one expandable support device 2 can be deployed into a single vertebra 142. For example, a first expandable support device (not shown) can be inserted through a first access port 172 and deployed in a first damage site 170, and a second expandable support device (not shown) can be inserted through a first access port 172 and deployed in a second damage site 188.


The first access port 172 can be substantially centered with respect to the first damage site 170. The first expandable support device (not shown) can expand, as shown by arrows 64, substantially equidirectionally, aligned with the center of the first access port 172. The second access port 186 can be substantially not centered with respect to the second damage site 188. The second expandable support device (not shown) can substantially anchor to a side of the damage site 146 and/or the surface of the disc 144, and then expand, as shown by arrows 60, substantially directionally away from the disc 144.



FIG. 68 illustrates that the fluid pressure can be released from the balloon 134, and the balloon 134 can return to a pre-deployment configuration, leaving the expandable support element substantially fixed to the vertebra 142 at the damage site 146.


The access port 160 can have an access port diameter 192. The access port diameter 192 can be from about 1.5 mm (0.060 in.) to about 40 mm (2 in.), for example about 8 mm (0.3 in.). The access port diameter 192 can be a result of the size of the access tool 148 and in the unexpanded expandable support device 2. After the expandable support device 2 is deployed, the damage site 146 can have a deployed diameter 194. The deployed diameter 194 can be from about 1.5 mm (0.060 in.) to about 120 mm (4.7 in.), for example from about 10 mm (0.4 in.) to about 20 mm (0.8 in.), or from about 12 mm (0.47 in.) to about 16 mm (0.63 in.). The deployed diameter 194 can be greater than, equal to, or less than the access port diameter 192.



FIG. 69 illustrates that the deployment tool 132 can be removed, as shown, from the vertebra 142 after the expandable support device 2 is deployed.



FIGS. 70 and 71 illustrate that a locking pin 196 can be inserted, as shown by arrow, into the deployed expandable support device 2, for example, after the expandable support device 2 is deployed in the vertebra 142. The locking pin 196 can prevent the expandable support device 2 from collapsing after the expandable support device 2 is deployed in the vertebra 142. The locking pin 196 can form an interference fit with the expandable support device 2 or may include features to hold the locking pin in place.


The locking pin 196 can be parallel with the longitudinal axis 80, as shown in FIG. 72, for example when the locking pin 196 is slidably received by and/or attached to the lock grooves 92 (see for example, FIG. 25). The locking pin 196 can be perpendicular to the longitudinal axis 80, as shown in FIG. 71, for example when the locking pin 196 is slidably received by and/or attached to ports formed between adjacent first struts 84 after the expandable support device 2 is expanded.



FIGS. 72 through 77 illustrate various methods for deploying the locking pin 196 into the expandable support device 2. As shown in FIGS. 72 and 73, the locking pin 196 can be translated, as shown by arrow, into the expandable support device 2 along the implant longitudinal axis. As shown in FIG. 74, a first end of the locking pin 196 can be translated, as shown by arrow, at an oblique angle, into a first port 16 formed between adjacent first struts 84. As shown by FIG. 75, a second end of the locking pin 196 can be rotated, as shown by arrow. As shown by FIG. 76, the second end of the locking pin 196 can be translated, as shown by arrow, into a second port 18 formed between adjacent first struts 84. FIG. 77 shows the locking pin 196 deployed into, and forming an interference fit with, the expandable support device 2.



FIG. 78 illustrates a slidable expansion device 198. The slidable expansion device 198 can have an expansion component 200, a deployment extension 202, a handle 204, or combinations thereof. The expansion component 200 can be configured to radially and/or longitudinally expand. The expansion component 200 can expand directly against tissue and/or expand an implant pre-loaded into the deployment site, and/or loaded onto or into the expansion component 200.


The expansion component 200 can have a first slidable element 206 and a second slidable element 208. The first and second slidable elements 206 and 208 can be configured to slide relative to each other. An interface 210 can be provided between the first slidable element 206 and the second slidable element 208. The expansion component 200 optionally can have an engagement element, such as an external engagement rib or thread 212. The external engagement thread 212 can spiral around the expansion component 200. The interface 210 can intersect the external engagement thread 212.


The deployment extension 202 can have a first extension arm 214 and a second extension arm 216. The first extension arm 214 can be fixedly attached to a third fixed element, such as the handle 204. The first extension arm 214 can be fixedly attached to the expansion component 200. The first extension arm 214 can maintain a substantially constant distance between the handle 204 and the first slidable element 206. The second extension arm 216 can be fixedly attached to the slidable expansion device 198 and slidably attached to the third fixed element, such as the handle 204.


The angle between an extension arm longitudinal axis 218, such as an axis extending along the second extension arm 216, and the interface 210 can form an expansion angle 220. The expansion angle 220 can be from about 0° to about 85°, more narrowly from about 10° to about 45°, for example about 30°.


The handle 204 can have an activation system configured to expand the expansion component 200. For example, the handle 204 can have a lever 222 than can be fixedly or rotatably attached to the second extension arm 216. The lever 222 can be rotatably attached to a lever pivot 224. The lever pivot 224 can be fixedly attached to a case of the handle 204. A return spring 226 can be attached to the lever 222. The return spring 226 can apply a force against the lever 222 sufficient to keep the lever 222 against a first stop 228 when the slidable expansion device 198 is not in use.



FIG. 79 illustrates that the expandable support device 2 can be loaded onto the expansion component 200 of the slidable expansion device 198. The expandable support device 2 can be translated, as shown by arrow 230, to the expansion component 200. The optional engagement groove 36 can be aligned with and engage the optimal external engagement rib or thread 212, such as by rotating the expandable support device 2, to engage thread and load the expandable support device 2 onto the expansion component 200.



FIG. 80 illustrates that, when loaded on the slidable expansion device 198, the expandable support device 2 (shown in see-through without details) can have an expandable support device diameter 234.



FIG. 81 illustrates that the lever 222 can be forced to retractably rotate, as shown by arrow 236, the second extension arm 216. The movement of the lever 222 can compress the return spring 226. The rotation of the lever 222 can be limited by physical interference at the second stop 238. The translation of the second extension arm 216 can, in turn, translate, as shown by arrow 240 the second slidable element 208. As the second slidable element 208 translates along the interface 210, the second slidable element 208 can shift downward (with respect to the page) and the first slidable element 206 can shift upward, thereby causing expansion, as shown by arrows 242, of the expansion component 200 and the expandable support device 2. The expandable support device diameter 234 can be larger after expansion than before expansion. The first extension arm 214 and/or the second extension arm 216 can resiliently and/or deformably flex during expansion of the expansion component 200.



FIG. 82 illustrates that the first and/or second slidable element 206 and/or 208 can have no external engagement thread 212. The first and/or second slidable element 206 and/or 208 can be coated or lubricated with a low-friction material, such as TEFLON® PTFE) from E. I. Du Pont de Nemours and Company, Wilmington, Del.



FIG. 83 illustrates that the force can be removed from the lever 222. The return spring 226 can translate, as shown by arrow 244. The lever 222 can be rotated, as shown by arrow 246, by the return spring 226, The first stop 228 can limit the rotation of the lever 222. The second extension arm 216 can translate, as shown by arrow 248, the second slidable element 208. The expansion component 200 can return to a contracted configuration. The expansion component 200 can be removed from the then-expanded expandable support device 2. While the deployment device of FIGS. 78-83, for example, shows a pistol type grip with a compressible handle, it also is contemplated that the device could be actuated by a rotational motion about the longitudinal axis of the deployment component.



FIGS. 84 and 85 illustrate that the expansion component 200 can have a substantially triangular, or wedge-shaped first and second slidable elements 206 and 208. As discussed above with respect to FIGS. 15 and 16, wedge shaped elements 96 and 98 may be incorporated into the expandable device. Translation of wedges within the device can assist in the deployment of the expandable device and may provide reinforcement for the deployed device. In this regard, it is contemplated that the various wedge, locking pin or buttress configurations disclosed herein could aid in deployment and provide rigid support for the expandable device. By way of example, wedge configurations as shown in FIGS. 84-99, which may include interlocking directional teeth or a tongue and groove interface as described with regard to the buttress of FIGS. 133-135, may be included as part of the expandable device. These features can provide expansion force to the device and added support and rigidity to the device in addition to struts 10, 12. The combined effect of the wedges with the struts provides the desirable combination of controlled expansion of the device with balanced counterforces within the device (the wedges opposing the struts and vice versa) so that the device may be deployed to the desired location and degree of expansion, the counterforce of the interlocking wedges and the struts establishing a uniform structure not prone to release or collapse.



FIGS. 86 and 87 illustrate that a first slidable element force, shown by arrow 250, can be applied to the first slidable element 206 in substantially the opposite direction as a second slidable element force, shown by arrow 252, can be applied to the second slidable element 208. The first slidable element 206 and the second slidable element 208 can translate, as shown by arrows 254 and 248, in opposite directions with respect to each other parallel to the interface 210 to cause expansion.



FIGS. 88 and 89 illustrate that the expansion component 200 can have substantially triangular or wedge-shaped first and second slidable; elements 206 and 208. The expansion component 200 can have multiple first slidable elements 206 and multiple interfaces 210.



FIGS. 90 and 91 illustrate that a first slidable element force, shown by arrow 250, can be applied to the first slidable elements 206 in substantially the opposite direction as a second slidable element force, shown by arrow 252, can be applied to the second slidable element 208. The first slidable elements 206 and the second slidable element 208 can translate, as shown by arrows 254 and 248.



FIGS. 92 and 93 illustrate that the expansion component 200 can have a first slidable; element 206 that can be flexibly resilient or deformably and can have a conical port therein. The second slidable element 208 can be substantially conical and can be positioned in the conical port of the first slidable element 206.



FIGS. 94 and 95 illustrate that a first slidable element force, shown by arrow 250, can be applied to the first slidable element 206 in substantially the opposite direction as a second slidable element force, shown by arrow 252 can be applied to the second slidable element 208. The first slidable element 206 can translate, as shown by arrows 254. The first slidable element 206 can resiliently or deformably expand radially outward.



FIGS. 96 and 97 illustrate that the expansion component 200 can have multiple first slidable elements 206 that can be flexibly resilient or deformably and can have a conical port therein. The first slidable elements 206 can be segmented or separated by element separations 148. The element separations 256 can be thinned and very low resistant or completely severed areas or lines (as shown). The second slidable element 208 can be substantially conical and can be positioned in the conical port of the first slidable element 206.



FIGS. 98 and 99 illustrate that first slidable element forces, shown by arrow 250, can be applied to the first slidable elements 206 in substantially the opposite direction as a second slidable element force, shown by arrow 252, can be applied to the second slidable element 208. The first slidable elements 206 can translate, as shown by arrows 254. The first slidable elements 206 can resiliently or deformably expand radially outward. The first slidable elements 206 can be attached by a filament or thin strip of material (not shown), or can be distinct and unattached to each other.



FIGS. 100 and 101 illustrate that the expansion component 200 can have a first slidable element 206 that can be rotatably attached to a second slidable element 208 via a hinge 150. The hinge 258 can rotate about a hinge pin 260 that can pass through the first slidable element 206 and the second slidable element 208. The second slidable element 208 can have a cam 262. A camshaft 264 can rotatably attach the cam 262 to the second slidable element 208. The cam 262 can be attached to all or part of the deployment extension 202. The cam 262 can be located in a depression or cavity in the second slidable element 208.



FIGS. 102 and 103 illustrate that the deployment extension 202 can be translated, as shown by arrow 266. This translation can rotate, as shown by arrow 268, the cam 262. The cam 262 can slide along the first slidable element 206 and can cause the first slidable element 206 to rotate, as shown by arrow 254, about the hinge pin 260.



FIG. 104 illustrates that the first slidable element 206 can have a slidable element port 270. The slidable element port 270 can be shaped (e.g., grooved or threaded) to receive the second slidable element 208. The second slidable element 208 can be conical. The second slidable element 208 can have a slidable element thread 272. The slidable element port 270 can be threaded. The second slidable element 208 can be translated, as shown by arrow 248 and rotated, as shown by arrow 274, as the second slidable element 208 approaches the slidable element port 270.



FIG. 105 illustrates that the second slidable element 208 can enter the slidable element port 270. The first slidable element 206 can expand, as shown by arrows 276, as the slidable element port 270 receives the second slidable element 208. The slidable element thread 272 can engage the slidable element port 270. The second slidable element 208 can be rotated, as shown by arrows 274, as the second slidable element 208 enters the first slidable element 206.



FIG. 106 illustrates an alternative deployment tool 132 can having a shaft 278 and a sleeve 280. The shaft 278 can be slidably received, as shown by arrow, by the sleeve 280. The shaft 278 can have a first catch 282. The shaft 278 can have a relief 284 section or an additional catch on a side opposite the first catch 282. The sleeve 280 can have a second catch 286.



FIG. 107 illustrates that the deployment tool 132 can have an actuator 288, such as an ergonomic lever handle 152. The handle 152 can be attached to the sleeve 280. When the shaft 278 is received in the sleeve 280, the actuator 288 can be attached to the shaft 278. Applying a force to the actuator 288 can cause the shaft 278 to slide or translate in the sleeve 280.



FIG. 108 illustrates that the expandable support device 2, for example in a contracted configuration, can be loaded on the shaft 278. The first end 4 of the expandable support device 2 can be received by and/or interference fit in the first catch 282. The second end 6 of the expandable support device 2 can be received by and/or interference fit in the relief 284. The first and/or second end 6 of the expandable support device 2 can be beveled. The beveled ends can be shaped to fit the first catch 282 and/or relief 284.



FIG. 109 illustrates that the shaft 278 can slide, as shown by arrow, relative to the sleeve 282. The second end 6 of the expandable support device 2 can be received by and/or engage the second catch 286. The second end 6 can interference fit the second catch 286.



FIG. 110 illustrates that the shaft 278 can be forcibly slid into the sleeve 282 by squeezing the lever handle (see FIG. 107). The expandable support device 2 can be squeezed between the first catch 282 and the second catch 286. The expandable support device 2 can be resiliently and/or deformably forced into an expanded configuration. The expandable support device 2 can be released from the deployment tool 132, for example, by releasing the shaft 278 from the handle and sliding the shaft 278 distally through the sleeve 282.



FIG. 111 illustrates that the expandable support device 2 can be expanded by applying force, as shown by arrows, on the first end 4 and the second end 6, and by directing the force toward the expandable support device 2. FIG. 112 illustrates that the expandable support device 2 can be expanded by applying force, as shown by arrows, radially outward against the wall 8.



FIGS. 113 and 114 illustrate various variations of the expandable support device 2 in an expanded configuration. The wall openings 112 can expand when the expandable support device 2 is in an expanded configuration.


The expandable support device 2 can have an expanded height 290 and an expanded length 292. The expanded height 290 can be from about 0.3 cm (0.1 in) to about 5 cm (2 in.), for example about 2 cm (0.6 in.). The expanded length 292 can be from about 0.1 cm (0.05 in) to about 3.8 cm (1.5 in.), for example about 3 cm (1 in.). The expandable support device 2 can have first 294 and second 296 expanded intersection angles. The first expanded intersecting angle 294 can be substantially equal to the second expanded intersecting angle 296. The expanded intersecting angles can be from about 45° to about 135°, for example about 110°, also for example about 90°.



FIG. 115 illustrates that the fluid pressure can be released from the balloon 134, and the balloon 134 can return to a pre-deployment configuration, leaving the expandable support element substantially fixed to the vertebra 142 at the damage site 146.


The access port 160 can have an access port diameter 192. The access port diameter 192 can be from about 1.5 mm (0.060 in.) to about 40 mm (2 in.), for example about 8 mm (0.3 in.). The access port diameter 192 can be a result of the size of the access tool 148. After the expandable support device 2 is deployed, the damage site 146 can have a deployed diameter 194. The deployed diameter 194 can be from about 1.5 mm (0.060 in.) to about 120 mm (4.7 in.), for example about 20 mm (0.8 in.). The deployed diameter 194 can be greater than, equal to, or less than the access port diameter 192.



FIG. 116 illustrates that the deployment tool 132 can be removed, as shown by arrow, from the vertebra 142 after the expandable support device 2 is deployed.



FIG. 117 illustrate that a second expandable support device 46 and/or locking pin 196 can be inserted, as shown by arrow 298, into the first deployed expandable support device 2, for example, after the first expandable support device 40 is deployed in the vertebra 142. The second expandable support device 46 and/or locking pin 196 can prevent the first expandable support device 40 from collapsing after the first expandable support device 40 is deployed in the vertebra 142. The second expandable support device 46 and/or locking pin 196 can form an interference fit with the expandable support device 2.



FIG. 118 illustrates that the second expandable support device 46 can be translated, as shown by arrow, into the first expandable support device 40. The first expandable support device 40 can be in an expanded, contracted, or other configuration. The second expandable support device 46 can be in an expanded, contracted, or other configuration. The struts 10 and/or wall openings 112 of the first expandable support device 40 can be angled in a substantially opposite direction to the struts 10 and/or wall openings 112 of the second expandable support device 46.



FIG. 119 illustrates that after the second expandable support device 46 is inside the first expandable support device 40, the second expandable support device 46 can be subject to any or all of the expansion forces, as shown by arrows.



FIG. 120 illustrates that the second expandable support device 46 can be in an expanded configuration in the first expandable support device 40. The second expandable support device 46 can be translated into the first expandable support device 40 and expanded, as shown in FIGS. 118 and 119. The second expandable support device 46 can be in an expanded configuration and screwed or otherwise attached into the first expandable support device 40.



FIG. 121 illustrates that the first expandable support device 40 can be rotatably attached to, or have an interference fit with, the second expandable support device 46. The first expandable support device 40 can have first teeth 300, for example on the inside surface of the wall 8. The second expandable support device 46 can have second teeth 302, for example on the outside surface of the wall 8. The first teeth 300 can engage the second teeth 302.



FIG. 122 illustrates a buttress 304. The buttress 304 can have a longitudinal axis 80. The buttress 304 can have a tensioner 306. A first end 4 of the tensioner 306 can be fixedly or removably attached a first end 4 of the buttress 304. A second end 6 of the tensioner 306 can be fixedly or removably attached a second end 6 of the buttress 304. The tensioner 306 can be in a relaxed configuration when the buttress 304 is in a relaxed configuration. The tensioner 306 can create a tensile force between the first end 4 of the buttress 304 and the second end 6 of the buttress 304 when the buttress 1304 is in a stressed configuration. The tensioner 306 can be, for example, a resilient wire, a coil, spring, an elastic member, or combinations thereof.


The buttress 304 can have a coil 308. The coil 308 can have turns 310 of a wire, ribbon, or other coiled element. FIGS. 123 through 125 illustrate that the coil 310 can be made from a wire, ribbon, or other coiled element having a circular, square, or oval cross-section, respectively.


The buttress 304 can be a series of connected hoops.



FIG. 126 illustrates that the buttress 304 can be loaded into a hollow deployment tool 132 in a smear (i.e., partially shear stressed) configuration at a smear section 310. The buttress 304 in the smear section 310 can have a relaxed first end 4, a stressed smear section 310, and a relaxed second end 6. The longitudinal axis 80 can be not straight (i.e., non-linear) through the smear section 310.



FIG. 127 illustrates that part of the buttress 304 can be forced, as shown by arrow, out of the deployment tool 132. The second end 6 can exit the deployment tool 132 before the remainder of the buttress 304. The smear section 310 can then partially relax. The second end 6 can be positioned to a final location before the remainder of the buttress 304 is deployed from the deployment tool 132.



FIG. 128 illustrates that the remainder of the buttress 304 can be forced, as shown by arrow, out of the deployment tool 132. The smear section 310 can substantially relax. The longitudinal axis 80 can return to a substantially relaxed and/or straight (i.e., linear) configuration.



FIG. 129 illustrates that the buttress 304 can be deployed 312 in the expandable support device 2, for example with the longitudinal axis 80 of the buttress 304 or the strongest orientation of the buttress 304 aligned substantially parallel with the primary load bearing direction (e.g., along the axis of the spine) of the expandable support device 2.



FIG. 130 illustrates that the buttress 304 can be loaded into the hollow deployment tool 132 with the longitudinal axis 80 of the buttress 1304 substantially parallel with the hollow length of the deployment tool 132. The entire length of the buttress 304 can be under shear stress.



FIG. 131 illustrates that part of the buttress 304 can be forced, as shown by arrow, out of the deployment tool 132. The second end 6 of the buttress 304 can exit the deployment tool 132 before the remainder of the buttress 304. The tensioner 306 can apply a tensile stress between the ends of the buttress 304, for example, forcing the deployed second end 6 of the buttress 304 to “stand up straight”. The second end 6 of the buttress 304 can be positioned to a final location before the remainder of the buttress 304 is deployed from the deployment tool 132.



FIG. 132 illustrates that the remainder of the buttress 304 can be forced, as shown by arrow, out of the deployment tool 132. The buttress 304 can substantially relax.



FIG. 133 illustrates that the buttress 304 can have a first wedge 66 and a second wedge 68. The first wedge 66 can contact the second wedge 68 at a directionally locking interface 314. The directionally locking interface 314 can have directional teeth 316.



FIG. 134 illustrates that the first wedge 66 can be slidably attached to the second wedge 68. The first wedge 66 can have a tongue 318. The second wedge 68 can have a groove 320. The tongue 318 can be slidably attached to the groove 320.


A gap 322 can be between the tongue 318 and the groove 320. The gap 322 can be wider than the height of the teeth 316. The gap 322 can be configured to allow the first wedge 66 to be sufficiently distanced from the second wedge 68 so the teeth 316 on the first wedge 66 can be disengaged from the teeth 316 on the second wedge 68.


The buttress 304 in a compact configuration can be placed inside of a fully or partially deployed expandable support device 2. FIG. 135 illustrates that the first wedge 66 can then be translated, as shown by arrows, relative to the second wedge 68 along the directionally locking interface 314. The first wedge 66 can abut a first side of the inside of the deployed expandable support device 2. The second wedge 68 can abut a second side of the inside of the deployed expandable support device 2. The directionally interference fitting teeth 316 can prevent disengagement of the buttress 304. A stop 324 can limit the relative translation of the first wedge 66 and the second wedge 68.



FIGS. 136 through 139 illustrate another form of expandable support device 2 of FIGS. 17 through 20 that can be in a deployed configuration. The first struts 84 can be expanded, as shown by arrows 326. The expandable support device 2 can be passively narrow, as shown by arrows 330. The expandable support device 2 can be deployed in a configuration where the second struts 86 can be placed against the load bearing surfaces of the deployment site.


The expandable support device 2 can have a minimum inner diameter 330 and a maximum inner diameter 332. The minimum inner diameter 330 can be less than the pre-deployed inner diameter. The minimum inner diameter 330 can be from about 0.2 mm (0.01 in.) to about 120 mm (4.7 in.), for example about 2 mm (0.08 in.). The diameters 330 and/or 332 can also be from about 1.5 mm (0.060 in.) to about 40 mm (2 in.), for example about 8 mm (0.3 in.). The maximum inner diameter 332 can be more than the pre-deployed inner diameter. The maximum inner diameter 332 can be from about 1.5 mm (0.060 in.) to about 120 mm (4.7 in.), for example about 18 mm (0.71 in.).



FIGS. 140 through 142 illustrate the expandable support device 2 of FIGS. 31 through 34 that can be in a deployed configuration. A tool (not shown) can releasably attach to the tool engagement port 106. The tool can be used to position the expandable support device 2. The tool can be used to expand the expandable support device 2, for example, by forcing the first panels 96 toward each other.


The second joints 104 can form angles less than about 90°. As shown in FIG. 143, a compressive force, as shown by arrows 334, causes additional inward deflection, as shown by arrows 336, of the first panels 96, and will not substantially compress the expandable support device 2.



FIG. 144 illustrates a deployed configuration of the expandable support device 2 of FIGS. 35 and 36. The first struts 84 can expand to the size of the expandable support device 2. FIG. 145 illustrates that the first struts 84 can touch each other, for example if the expandable support device 2 is sufficiently expanded. In the case of extreme compressive loads applied to the expandable support device 2, the first struts 84 can buckle into each other, thereby providing additional resistance to compressive loads.



FIG. 146 illustrates the expandable support device 2 that can have one or more hands 130. The bands 338 can be attached to other bands 338 and/or attached to the expandable support device 2 with band connectors 340. The hands 338 can be attached to the expandable support device 2 before, during, or after deployment. The bands 338 can increase the compressive strength of the expandable support device 2.



FIG. 147 illustrates a locking pin 196 configured and dimensioned to fit into the longitudinal port 82, for example, of the expanded expandable support device 2 of FIGS. 136 through 139. FIG. 148 illustrates a the locking pin 196 configured and dimensioned to fit into the longitudinal port 82, for example, of the expanded expandable support device 2 of FIGS. 140 through 143. FIG. 149 illustrates a locking pin 196 configured and dimensioned to fit into the longitudinal port 82, for example, of the expanded expandable support device 2 of FIGS. 24 and 25 and/or FIGS. 27 and 28.


Once the expandable support device 2 is deployed, the longitudinal port 82 and the remaining void volume in the damage site 146 can be filled with, for example, biocompatible coils, bone cement, morselized bone, osteogenic powder, beads of bone, polymerizing fluid, paste, a matrix containing an osteogenic agent and/or an anti-inflammatory agent, and/or any other agent disclosed supra), Orthofix, cyanoacrylate, or combinations thereof.


The expandable support device 2 can be implanted in the place of all or part of a vertebral disc 144. For example, if the disc 144 has herniated, the expandable support device 2 can be implanted into the hernia in the disc 144 annulus, and/or the expandable support device 2 can be implanted into the disc 144 nucleus.


PCT Application No. PCT/US2005/033965, Publication No. WO 2006/034396, entitled “Balloon and Methods of flaking and Using”, filed Sep. 21, 2005, and U.S. Provisional Patent Application Ser. No. 60/611,972, filed on Sep. 21, 2004, are herein incorporated by reference in their entireties. PCT Application No. PCT/US2005/034728, Publication No. WO 2006/068,682, entitled “Expandable Support Device and Method of Use”, filed Sep. 26, 2005, and U.S. Provisional Patent Application No.: 60/612,728, filed on Sep. 24, 2004, are herein incorporated by reference in their entireties.


It is apparent to one skilled in the art that various changes and modifications can be made to this disclosure, and equivalents employed, without departing from the spirit and scope of the invention. Elements shown with any variation are exemplary for the specific variation and can be used on other variations within this disclosure. Any elements described herein as singular can be pluralized (i.e., anything described as “one” can be more than one). Any species element of a genus element can have the characteristics or elements of any other species element of that genus. The above-described configurations, elements or complete assemblies and methods and their elements for carrying out the invention, and variations of aspects of the invention can be combined and modified with each other in any combination.

Claims
  • 1. An expandable implant device comprising: a body having a body longitudinal axis, a body first surface, and a body second surface, wherein the body first surface is opposite the body second surface, and wherein the body first surface and the body second surface have slopes at equal and opposite angles with respect to the body longitudinal axis;a first external component having a first external component outer surface and a first external component inner surface, and wherein the first external component inner surface is in slidable contact with the body first surface, and wherein the first external component inner surface has a slope at an equal angle with respect to the body longitudinal axis as the angle of the body first surface with respect to the body longitudinal axis;a second external component having a second external component outer surface and a second external component inner surface, and wherein the second external component inner surface is in slidable contact with the body second surface, and wherein the second external component inner surface has a slope at an equal angle with respect to the body longitudinal axis as the angle of the body second surface with respect to the body longitudinal axis;wherein the expandable implant device has a first configuration and a second configuration, and wherein when the expandable implant device is in the first configuration and the expandable implant device is viewed in a transverse direction, a first longitudinal end of the first external component outer surface is co-terminal with a first longitudinal end of the second external component outer surface in a longitudinal direction, and wherein a second longitudinal end of the first external component outer surface is co-terminal with a second longitudinal end of the second external component outer surface in the longitudinal direction, anda first longitudinal end of the first external component inner surface is co-terminal with a first longitudinal end of the second external component inner surface in the longitudinal direction, and wherein a second longitudinal end of the first external component inner surface is co-terminal with a second longitudinal end of the second external component inner surface in the longitudinal direction; andwherein when the expandable implant device is in the second configuration and the expandable implant device is viewed in the transverse direction, the first longitudinal end of the first external component outer surface is co-terminal with the first longitudinal end of the second external component outer surface in the longitudinal direction, and wherein the second longitudinal end of the first external component outer surface is co-terminal with the second longitudinal end of the second external component outer surface in the longitudinal direction, andthe first longitudinal end of the first external component inner surface is co-terminal with the first longitudinal end of the second external component inner surface in the longitudinal direction, and wherein the second longitudinal end of the first external component inner surface is co-terminal with the second longitudinal end of the second external component inner surface in the longitudinal direction;wherein the first external component outer surface has ridges that extend away from the body longitudinal axis, wherein the first external component inner surface is a portion of a tongue, wherein the body first surface is a portion of a groove, wherein the tongue is slidable in and attachably engageable with the groove, wherein the tongue has a smooth surface and a tongue longitudinal axis angled relative to the body longitudinal axis, wherein the groove has a smooth surface and a groove longitudinal axis angled relative to the body longitudinal axis, wherein the tongue and the groove permit relative longitudinal movement of the first external component and the body along the body longitudinal axis such that the first external component and the second external component are closer to the body longitudinal axis when the expandable implant device is in the first configuration than when the expandable implant device is in the second configuration, wherein the tongue and the groove restrict relative lateral movement of the first external component and the body along a lateral axis perpendicular to the body longitudinal axis, wherein the tongue and the groove restrict relative transverse movement of the first external component and the body along a transverse axis perpendicular to the groove longitudinal axis,wherein when the expandable implant device is in the first configuration, the first external component inner surface is in slidable contact with the body first surface, wherein when the expandable implant device is in the first configuration, the second external component inner surface is in slidable contact with the body second surface,wherein when the expandable implant device is in the second configuration, the first external component inner surface is in slidable contact with the body first surface, wherein when the expandable implant device is in the second configuration, the second external component inner surface is in slidable contact with the body second surface,wherein the second configuration is an implantable configuration of the expandable implant device, wherein when the expandable implant device is in the second configuration, a longitudinal terminal end of the first external component is longitudinally offset from a longitudinal terminal end of the body, wherein when the expandable implant device is in the second configuration, a longitudinal terminal end of the second external component is longitudinally offset from the longitudinal terminal end of the body, andwherein when the expandable implant device is in the implantable configuration, the tongue is slidable in the groove along the groove longitudinal axis.
  • 2. The expandable implant device of claim 1, wherein the first configuration is a height-contracted configuration, and wherein the second configuration is a height-expanded configuration.
  • 3. The expandable implant device of claim 1, wherein the first external component inner surface and the body first surface have a directionally locking interface.
  • 4. The expandable implant device of claim 3, wherein the first external component inner surface has first directional teeth, and wherein the body first surface has second directional teeth, and wherein the directionally locking interface comprises the first directional teeth and the second directional teeth.
  • 5. The expandable implant device of claim 3, wherein the second external component inner surface and the body second surface have a directionally locking interface.
  • 6. The expandable implant device of claim 1, wherein the expandable implant device has a different proximal terminal end when the expandable implant device is in the first configuration than when the expandable implant device is in the second configuration.
  • 7. The expandable implant device of claim 1, wherein when the expandable implant device is in the first configuration, the expandable implant device has a first proximal terminal end, and wherein when the expandable implant device is in the second configuration, the expandable implant device has a second proximal terminal end, and wherein the first proximal terminal end is different from the second proximal terminal end.
  • 8. The expandable implant device of claim 1, wherein when the expandable implant device is in the first configuration, the expandable implant device has a proximal terminal end at a first longitudinal position relative to the body longitudinal axis, wherein when the expandable implant device is in the second configuration, the proximal terminal end is at a second longitudinal position relative to the body longitudinal axis, and wherein the first longitudinal position is different from the second longitudinal position.
  • 9. The expandable implant device of claim 1, wherein the expandable implant device is longitudinally compressed in the first configuration when compared to the second configuration.
  • 10. The expandable implant device of claim 1, wherein the tongue and the groove extend longitudinally along the body longitudinal axis, wherein when the expandable implant device is in the first configuration, the expandable implant device is insertable in a target site, and wherein when the expandable implant device is in the first configuration, the expandable implant device is expandable from the first configuration to the second configuration.
  • 11. The expandable implant device of claim 1, wherein when the expandable implant device is in the first configuration, the expandable implant device is insertable in a target site, and wherein when the expandable implant device is in the first configuration, the expandable implant device is expandable from the first configuration to the second configuration.
  • 12. An expandable implant device comprising: a body having a body longitudinal axis, a body first surface, and a body second surface, wherein the body first surface is opposite the body second surface, and wherein the body first surface and the body second surface have slopes at equal and opposite angles with respect to the body longitudinal axis;a first external component having a first external component outer surface and a first external component inner surface, and wherein the first external component inner surface is in slidable contact with the body first surface, and wherein the first external component inner surface has a slope at an equal angle with respect to the body longitudinal axis as the angle of the body first surface with respect to the body longitudinal axis;a second external component having a second external component outer surface and a second external component inner surface, and wherein the second external component inner surface is in slidable contact with the body second surface, and wherein the second external component inner surface has a slope at an equal angle with respect to the body longitudinal axis as the angle of the body second surface with respect to the body longitudinal axis;wherein the expandable implant device has a contracted configuration and an expanded configuration, wherein when the expandable implant device is in the contracted configuration and the expandable implant device is viewed in a transverse direction, a first longitudinal end of the first external component outer surface is co-terminal with a first longitudinal end of the second external component outer surface in a longitudinal direction, and wherein a second longitudinal end of the first external component outer surface is co-terminal with a second longitudinal end of the second external component outer surface in the longitudinal direction, anda first longitudinal end of the first external component inner surface is co-terminal with a first longitudinal end of the second external component inner surface in the longitudinal direction, and wherein a second longitudinal end of the first external component inner surface is co-terminal with a second longitudinal end of the second external component inner surface in the longitudinal direction; andwherein when the expandable implant device is in the expanded configuration and the expandable implant device is viewed in the transverse direction, the first longitudinal end of the first external component outer surface is co-terminal with the first longitudinal end of the second external component outer surface in the longitudinal direction, and wherein the second longitudinal end of the first external component outer surface is co-terminal with the second longitudinal end of the second external component outer surface in the longitudinal direction, andthe first longitudinal end of the first external component inner surface is co-terminal with the first longitudinal end of the second external component inner surface in the longitudinal direction, and wherein the second longitudinal end of the first external component inner surface is co-terminal with the second longitudinal end of the second external component inner surface in the longitudinal direction;wherein the first external component inner surface is a portion of a tongue, wherein the body first surface is a portion of a groove, wherein the groove has a groove longitudinal axis angled relative to the body longitudinal axis, wherein the tongue is slidable in the groove, wherein the tongue and the groove permit relative longitudinal movement of the first external component and the body along the body longitudinal axis, wherein the tongue and the groove restrict relative lateral movement of the first external component and the body along a lateral axis perpendicular to the body longitudinal axis, wherein the tongue and the groove restrict relative transverse movement of the first external component and the body along a transverse axis perpendicular to the groove longitudinal axis, wherein a first portion of the groove is on a body first side and wherein a second portion of the groove is on a body second side,wherein when the expandable implant device is in the contracted configuration, the first external component inner surface is in slidable contact with the body first surface, wherein when the expandable implant device is in the contracted configuration, the second external component inner surface is in slidable contact with the body second surface,wherein when the expandable implant device is in the expanded configuration, the first external component inner surface is in slidable contact with the body first surface, wherein when the expandable implant device is in the expanded configuration, the second external component inner surface is in slidable contact with the body second surface, andwherein the first external component and the second external component are closer to the body longitudinal axis when the expandable implant device is in the contracted configuration than when the expandable implant device is in the expanded configuration.
  • 13. The expandable implant device of claim 12, wherein the tongue has a tongue longitudinal axis angled relative to the body longitudinal axis, and wherein a first portion of the tongue is on a first external component first side and wherein a second portion of the tongue is on a first external component second side.
  • 14. The expandable implant device of claim 13, wherein when the expandable implant device is in the contracted configuration, the expandable implant device is insertable in a target site, and wherein when the expandable implant device is in the contracted configuration, the expandable implant device is expandable from the contracted configuration to the expanded configuration.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 14/933,820, filed Nov. 5, 2015, which is a continuation of U.S. patent application Ser. No. 11/689,465, filed Mar. 21, 2007 (issued as U.S. Pat. No. 9,314,349 on Apr. 19, 2016), which is a continuation-in-part of PCT Application No. PCT/US2005/037126, filed Oct. 12, 2005 which claims priority to U.S. Provisional Application No. 60/617,810, filed Oct. 12, 2004; a continuation-in-part of PCT Application No. PCT/US2005/034115, filed Sep. 21, 2005, which claims priority to U.S. Provisional Application No. 60/612,001, filed Sep. 21, 2004; and a continuation-in-part of PCT Application No. PCT/US2005/034742, filed Sep. 26, 2005, which claims priority to U.S. Provisional Application No. 60/612,723, filed Sep. 24, 2004, and U.S. Provisional Application No. 60/612,724, filed Sep. 24, 2004, all of which are incorporated by reference herein in their entirety. This application also claims the benefit of all of the above-referenced U.S. Provisional applications.

US Referenced Citations (691)
Number Name Date Kind
646119 Clamer et al. Mar 1900 A
4204531 Aginsky May 1980 A
4541423 Barber Sep 1985 A
4569338 Edwards Feb 1986 A
4636217 Ogilvie et al. Jan 1987 A
4653489 Tronzo Mar 1987 A
4716893 Fischer et al. Jan 1988 A
4725264 Glassman Feb 1988 A
4733665 Palmaz Mar 1988 A
4759769 Hedman et al. Jul 1988 A
4763644 Webb Aug 1988 A
4863476 Shepperd Sep 1989 A
4886062 Wiktor Dec 1989 A
4911718 Lee et al. Mar 1990 A
4932975 Main et al. Jun 1990 A
4941466 Romano Jul 1990 A
4969888 Scholten et al. Nov 1990 A
5007909 Rogozinski Apr 1991 A
5015247 Michelson May 1991 A
5026373 Ray et al. Jun 1991 A
5059193 Kuslich Oct 1991 A
5108404 Scholten et al. Apr 1992 A
5123926 Pisharodi Jun 1992 A
5139480 Hickle et al. Aug 1992 A
5171278 Pisharodi Dec 1992 A
5192327 Brantigan Mar 1993 A
5217483 Tower Jun 1993 A
5258031 Salib et al. Nov 1993 A
5306278 Dahl et al. Apr 1994 A
5324295 Shapiro, III Jun 1994 A
5342348 Kaplan Aug 1994 A
5345927 Bonutti Sep 1994 A
5390683 Pisharodi Feb 1995 A
5390898 Smedley et al. Feb 1995 A
5397364 Kozak et al. Mar 1995 A
5425773 Boyd et al. Jun 1995 A
5454365 Bonutti Oct 1995 A
5458643 Oka et al. Oct 1995 A
5480442 Bertagnoli Jan 1996 A
5484384 Fearnot Jan 1996 A
5496365 Sgro Mar 1996 A
5522899 Michelson Jun 1996 A
5534002 Brumfield et al. Jul 1996 A
5540690 Miller et al. Jul 1996 A
5549679 Kuslich Aug 1996 A
5554191 Lahille et al. Sep 1996 A
5556413 Lam Sep 1996 A
5562736 Ray et al. Oct 1996 A
5562738 Boyd et al. Oct 1996 A
5571189 Kuslich Nov 1996 A
5571192 Schonhoffer Nov 1996 A
5584831 McKay Dec 1996 A
5591197 Orth et al. Jan 1997 A
5593409 Michelson Jan 1997 A
5609356 Mossi Mar 1997 A
5609635 Michelson Mar 1997 A
5643264 Sherman et al. Jul 1997 A
5643312 Fischell et al. Jul 1997 A
5645560 Crocker et al. Jul 1997 A
5649950 Bourne et al. Jul 1997 A
5653763 Errico et al. Aug 1997 A
5658335 Allen Aug 1997 A
5665122 Kambin Sep 1997 A
5669909 Zdeblick et al. Sep 1997 A
5674295 Ray et al. Oct 1997 A
5683394 Rinner Nov 1997 A
5693100 Pisharodi Dec 1997 A
5702449 Mckay Dec 1997 A
5702453 Rabbe et al. Dec 1997 A
5741253 Michelson Apr 1998 A
5749916 Richelsoph May 1998 A
5772661 Michelson Jun 1998 A
5776181 Lee et al. Jul 1998 A
5776197 Rabbe et al. Jul 1998 A
5776198 Rabbe et al. Jul 1998 A
5776199 Michelson Jul 1998 A
5782832 Larsen et al. Jul 1998 A
5782903 Wiktor Jul 1998 A
5785710 Michelson Jul 1998 A
5800520 Fogarty et al. Sep 1998 A
5824054 Khosravi et al. Oct 1998 A
5824093 Ray et al. Oct 1998 A
5827289 Reiley et al. Oct 1998 A
5827321 Roubin et al. Oct 1998 A
5853419 Imran Dec 1998 A
5861025 Boudghene et al. Jan 1999 A
5863284 Klein Jan 1999 A
5865848 Baker Feb 1999 A
5895387 Guerrero et al. Apr 1999 A
5902475 Trozera et al. May 1999 A
5972015 Scribner et al. Oct 1999 A
5980522 Koros et al. Nov 1999 A
5980550 Eder et al. Nov 1999 A
5984957 Laptewicz et al. Nov 1999 A
5993483 Gianotti Nov 1999 A
6001130 Bryan et al. Dec 1999 A
6019765 Thornhill et al. Feb 2000 A
6019792 Cauthen Feb 2000 A
6022376 Assell et al. Feb 2000 A
6025104 Fuller et al. Feb 2000 A
6027527 Asano et al. Feb 2000 A
6036719 Meilus Mar 2000 A
6039761 Li et al. Mar 2000 A
6045579 Hochshuler et al. Apr 2000 A
6053916 Moore Apr 2000 A
6066154 Reiley et al. May 2000 A
6077246 Kullas et al. Jun 2000 A
6080158 Lin Jun 2000 A
6080193 Hochshuler et al. Jun 2000 A
6083522 Chu et al. Jul 2000 A
6086610 Duerig et al. Jul 2000 A
6090143 Meriwether et al. Jul 2000 A
6102619 Truebe et al. Aug 2000 A
6102950 Vaccaro Aug 2000 A
6113628 Borghi Sep 2000 A
6113639 Ray et al. Sep 2000 A
6126689 Brett Oct 2000 A
6127597 Beyar et al. Oct 2000 A
6129763 Chauvin et al. Oct 2000 A
6132465 Ray et al. Oct 2000 A
6140452 Felt et al. Oct 2000 A
6146417 Ischinger Nov 2000 A
6159244 Suddaby Dec 2000 A
6159245 Meriwether et al. Dec 2000 A
6168616 Brown Jan 2001 B1
6171312 Beaty Jan 2001 B1
6176882 Biedermann et al. Jan 2001 B1
6179874 Cauthen Jan 2001 B1
6183506 Penn et al. Feb 2001 B1
6183517 Suddaby Feb 2001 B1
6193757 Foley et al. Feb 2001 B1
6206910 Berry et al. Mar 2001 B1
6206924 Timm Mar 2001 B1
6224595 Michelson May 2001 B1
6224603 Marino May 2001 B1
6224604 Suddaby May 2001 B1
6224607 Michelson May 2001 B1
6235043 Reiley et al. May 2001 B1
6241734 Scribner et al. Jun 2001 B1
6245101 Drasler et al. Jun 2001 B1
6245107 Ferree Jun 2001 B1
6248110 Reiley et al. Jun 2001 B1
6280456 Scribner et al. Aug 2001 B1
6287332 Bolz et al. Sep 2001 B1
6293967 Shanley Sep 2001 B1
6296644 Saurat et al. Oct 2001 B1
6302914 Michelson Oct 2001 B1
6332895 Suddaby Dec 2001 B1
6371989 Chauvin et al. Apr 2002 B1
6387130 Stone et al. May 2002 B1
6395031 Foley et al. May 2002 B1
6402750 Atkinson et al. Jun 2002 B1
6402785 Zdeblick et al. Jun 2002 B1
6409765 Bianchi et al. Jun 2002 B1
6419704 Ferree Jul 2002 B1
6419705 Erickson Jul 2002 B1
6423083 Reiley et al. Jul 2002 B2
6425916 Garrison et al. Jul 2002 B1
6425919 Lambrecht Jul 2002 B1
6428569 Brown Aug 2002 B1
6432107 Ferree Aug 2002 B1
6436098 Michelson Aug 2002 B1
6436140 Liu et al. Aug 2002 B1
6440168 Cauthen Aug 2002 B1
6447544 Michelson Sep 2002 B1
6447546 Bramlet et al. Sep 2002 B1
6447547 Michelson Sep 2002 B1
6451025 Jervis Sep 2002 B1
6454804 Ferree Sep 2002 B1
6468301 Amplatz et al. Oct 2002 B1
6468302 Cox et al. Oct 2002 B2
6475237 Drasler et al. Nov 2002 B2
6478823 Michelson Nov 2002 B1
6482235 Lambrecht et al. Nov 2002 B1
6488710 Besselink Dec 2002 B2
6491724 Ferree Dec 2002 B1
6494883 Ferree Dec 2002 B1
6508820 Bales Jan 2003 B2
6508839 Lambrecht et al. Jan 2003 B1
6514255 Ferree Feb 2003 B1
6520991 Huene Feb 2003 B2
6533817 Norton et al. Mar 2003 B1
6551342 Shen et al. Apr 2003 B1
6554833 Levy et al. Apr 2003 B2
6562074 Gerbec et al. May 2003 B2
6582431 Ray Jun 2003 B1
6582467 Teitelbaum et al. Jun 2003 B1
6585770 White et al. Jul 2003 B1
6592589 Hajianpour Jul 2003 B2
6592625 Cauthen Jul 2003 B2
6595998 Johnson et al. Jul 2003 B2
6602291 Ray et al. Aug 2003 B1
6607530 Carl et al. Aug 2003 B1
6607544 Boucher et al. Aug 2003 B1
6613054 Scribner et al. Sep 2003 B2
6623505 Scribner et al. Sep 2003 B2
6641587 Scribner et al. Nov 2003 B2
6641614 Wagner et al. Nov 2003 B1
6645213 Sand et al. Nov 2003 B2
6645247 Ferree Nov 2003 B2
6648917 Gerbec et al. Nov 2003 B2
6648918 Ferree Nov 2003 B2
6648920 Ferree Nov 2003 B2
6652584 Michelson Nov 2003 B2
6656178 Veldhuizen et al. Dec 2003 B1
6663647 Reiley et al. Dec 2003 B2
6666891 Boehm et al. Dec 2003 B2
6676665 Foley et al. Jan 2004 B2
6679915 Cauthen Jan 2004 B1
6685695 Ferree Feb 2004 B2
6695760 Winkler et al. Feb 2004 B1
6706068 Ferree Mar 2004 B2
6706070 Wagner et al. Mar 2004 B1
6709458 Michelson Mar 2004 B2
6712853 Kuslich Mar 2004 B2
6716216 Boucher et al. Apr 2004 B1
6716247 Michelson Apr 2004 B2
6719773 Boucher et al. Apr 2004 B1
6723126 Berry Apr 2004 B1
6726691 Osorio et al. Apr 2004 B2
6733535 Michelson May 2004 B2
6736818 Perren et al. May 2004 B2
6740090 Cragg et al. May 2004 B1
6743255 Ferree Jun 2004 B2
6746451 Middleton et al. Jun 2004 B2
6758863 Estes et al. Jul 2004 B2
6793656 Mathews Sep 2004 B1
6793679 Michelson Sep 2004 B2
6808537 Michelson Oct 2004 B2
6814756 Michelson Nov 2004 B1
6830589 Erickson Dec 2004 B2
6852115 Kinnett Feb 2005 B2
6852123 Brown Feb 2005 B2
6852129 Gerbec et al. Feb 2005 B2
6863673 Gerbec et al. Mar 2005 B2
6893464 Kiester May 2005 B2
6899716 Cragg May 2005 B2
6899719 Reiley et al. May 2005 B2
6921264 Mayer et al. Jul 2005 B2
6923813 Phillips et al. Aug 2005 B2
6923830 Michelson Aug 2005 B2
6936065 Khan et al. Aug 2005 B2
6936070 Muhanna Aug 2005 B1
6948223 Shortt Sep 2005 B2
6953477 Berry Oct 2005 B2
6955691 Chae et al. Oct 2005 B2
6960215 Olson et al. Nov 2005 B2
6962606 Michelson Nov 2005 B2
6981981 Reiley et al. Jan 2006 B2
6988710 Igarashi Jan 2006 B2
7008453 Michelson Mar 2006 B1
7018415 McKay Mar 2006 B1
7018416 Hanson et al. Mar 2006 B2
7056321 Pagliuca et al. Jun 2006 B2
7060073 Frey et al. Jun 2006 B2
7066961 Michelson Jun 2006 B2
7077864 Byrd et al. Jul 2006 B2
7087055 Lim et al. Aug 2006 B2
7094257 Mujwid et al. Aug 2006 B2
7097648 Globerman et al. Aug 2006 B1
7112206 Michelson Sep 2006 B2
7118598 Michelson Oct 2006 B2
7135043 Nakahara et al. Nov 2006 B2
7166110 Yundt Jan 2007 B2
7201751 Zucherman et al. Apr 2007 B2
7201775 Gorensek et al. Apr 2007 B2
7204853 Gordon et al. Apr 2007 B2
7211112 Baynham et al. May 2007 B2
7223292 Messerli et al. May 2007 B2
7226475 Lenz et al. Jun 2007 B2
7226481 Kuslich Jun 2007 B2
7226483 Gerber et al. Jun 2007 B2
7238186 Zdeblick et al. Jul 2007 B2
7241297 Shaolian et al. Jul 2007 B2
7241303 Reiss et al. Jul 2007 B2
7300440 Zdeblick et al. Nov 2007 B2
7309338 Cragg Dec 2007 B2
7311713 Johnson et al. Dec 2007 B2
7316714 Gordon et al. Jan 2008 B2
7318826 Teitelbaum et al. Jan 2008 B2
7396360 Lieberman Jul 2008 B2
7431735 Liu et al. Oct 2008 B2
7452371 Pavcnik et al. Nov 2008 B2
7488337 Saab et al. Feb 2009 B2
7503933 Michelson Mar 2009 B2
7507241 Levy et al. Mar 2009 B2
7582106 Teitelbaum et al. Sep 2009 B2
7601172 Segal et al. Oct 2009 B2
7618457 Hudgins Nov 2009 B2
7621950 Globerman et al. Nov 2009 B1
7625395 Mückter Dec 2009 B2
7628807 Flanagan Dec 2009 B2
7722674 Grotz May 2010 B1
7749228 Lieberman Jul 2010 B2
7763028 Lim et al. Jul 2010 B2
7771463 Ton et al. Aug 2010 B2
7828849 Lim Nov 2010 B2
7837734 Zucherman et al. Nov 2010 B2
7846206 Oglaza et al. Dec 2010 B2
7867233 Shaolian et al. Jan 2011 B2
7875035 Boucher et al. Jan 2011 B2
7879036 Biedermann et al. Feb 2011 B2
7879082 Brown Feb 2011 B2
8007498 Mische Aug 2011 B2
8034110 Garner et al. Oct 2011 B2
8062375 Glerum et al. Nov 2011 B2
8105382 Olmos et al. Jan 2012 B2
8142507 McGuckin Mar 2012 B2
8162943 Justin et al. Apr 2012 B2
8206423 Siegal Jun 2012 B2
8246622 Siegal et al. Aug 2012 B2
8262737 Bagga et al. Sep 2012 B2
8425570 Reiley Apr 2013 B2
8465524 Siegal Jun 2013 B2
8486149 Saidha et al. Jul 2013 B2
8512408 Miller et al. Aug 2013 B2
8518120 Glerum et al. Aug 2013 B2
8535380 Greenhalgh et al. Sep 2013 B2
8551171 Johnson et al. Oct 2013 B2
8556979 Glerum et al. Oct 2013 B2
8579912 Isaza et al. Nov 2013 B2
8591582 Anderson et al. Nov 2013 B2
8672968 Stone et al. Mar 2014 B2
8672977 Siegal et al. Mar 2014 B2
8679183 Glerum et al. Mar 2014 B2
8685098 Glerum et al. Apr 2014 B2
8709042 Greenhalgh et al. Apr 2014 B2
8777993 Siegal et al. Jul 2014 B2
8845731 Weiman Sep 2014 B2
8845734 Weiman Sep 2014 B2
9050112 Greenhalgh et al. Jun 2015 B2
9149286 Greenhalgh et al. Oct 2015 B1
9216095 Glerum et al. Dec 2015 B2
9259329 Greenhalgh et al. Feb 2016 B2
9314349 Greenhalgh et al. Apr 2016 B2
9402739 Weiman et al. Aug 2016 B2
9408708 Greenhalgh Aug 2016 B2
9510885 Burger et al. Dec 2016 B2
9770339 Greenhalgh et al. Sep 2017 B2
10070968 Greenhalgh et al. Sep 2018 B2
10285819 Greenhalgh May 2019 B2
10285820 Greenhalgh May 2019 B2
10292828 Greenhalgh May 2019 B2
10758289 Greenhalgh et al. Sep 2020 B2
10940014 Greenhalgh Mar 2021 B2
20010007956 Letac et al. Jul 2001 A1
20010034552 Young et al. Oct 2001 A1
20020007218 Cauthen Jan 2002 A1
20020010511 Michelson Jan 2002 A1
20020022887 Huene Feb 2002 A1
20020032444 Mische Mar 2002 A1
20020038767 Trozera Apr 2002 A1
20020052656 Michelson May 2002 A1
20020068911 Chan Jun 2002 A1
20020068939 Levy et al. Jun 2002 A1
20020068975 Teitelbaum et al. Jun 2002 A1
20020068976 Jackson Jun 2002 A1
20020068977 Jackson Jun 2002 A1
20020082598 Teitelbaum Jun 2002 A1
20020082600 Shaolian et al. Jun 2002 A1
20020091390 Michelson Jul 2002 A1
20020095155 Michelson Jul 2002 A1
20020099378 Michelson Jul 2002 A1
20020111688 Cauthen Aug 2002 A1
20020120337 Cauthen Aug 2002 A1
20020123807 Cauthen Sep 2002 A1
20020128713 Ferree Sep 2002 A1
20020138077 Ferree Sep 2002 A1
20020138133 Lenz et al. Sep 2002 A1
20020138144 Michelson Sep 2002 A1
20020143401 Michelson Oct 2002 A1
20020151896 Ferree Oct 2002 A1
20020151980 Cauthen Oct 2002 A1
20020156530 Lambrecht et al. Oct 2002 A1
20020161367 Ferree Oct 2002 A1
20020161373 Osorio et al. Oct 2002 A1
20020165542 Ferree Nov 2002 A1
20020189622 Cauthen et al. Dec 2002 A1
20020198526 Shaolian et al. Dec 2002 A1
20030004511 Ferree Jan 2003 A1
20030004574 Ferree Jan 2003 A1
20030009227 Lambrecht et al. Jan 2003 A1
20030014118 Lambrecht et al. Jan 2003 A1
20030026788 Ferree Feb 2003 A1
20030032963 Reiss et al. Feb 2003 A1
20030040796 Ferree Feb 2003 A1
20030040798 Michelson Feb 2003 A1
20030050701 Michelson Mar 2003 A1
20030065394 Michelson Apr 2003 A1
20030065396 Michelson Apr 2003 A1
20030074076 Ferree et al. Apr 2003 A1
20030078579 Ferree Apr 2003 A1
20030088249 Furderer May 2003 A1
20030120345 Cauthen Jun 2003 A1
20030125748 Li et al. Jul 2003 A1
20030125807 Lambrecht et al. Jul 2003 A1
20030135220 Cauthen Jul 2003 A1
20030135279 Michelson Jul 2003 A1
20030149482 Michelson Aug 2003 A1
20030153976 Cauthen et al. Aug 2003 A1
20030158553 Michelson Aug 2003 A1
20030158604 Cauthen et al. Aug 2003 A1
20030163200 Cauthen Aug 2003 A1
20030171813 Kiester Sep 2003 A1
20030181979 Ferree Sep 2003 A1
20030181980 Berry et al. Sep 2003 A1
20030181983 Cauthen Sep 2003 A1
20030187507 Cauthen Oct 2003 A1
20030187508 Cauthen Oct 2003 A1
20030191536 Ferree Oct 2003 A1
20030195514 Trieu et al. Oct 2003 A1
20030195630 Ferree Oct 2003 A1
20030195631 Ferree Oct 2003 A1
20030199979 Mcguckin Oct 2003 A1
20030199981 Ferree Oct 2003 A1
20030204189 Cragg Oct 2003 A1
20030204260 Ferree Oct 2003 A1
20030208270 Michelson Nov 2003 A9
20030220643 Ferree Nov 2003 A1
20030220650 Major et al. Nov 2003 A1
20030220690 Cauthen Nov 2003 A1
20030220693 Cauthen Nov 2003 A1
20030220694 Cauthen Nov 2003 A1
20030233097 Ferree Dec 2003 A1
20030233148 Ferree Dec 2003 A1
20030236520 Lim et al. Dec 2003 A1
20040002759 Ferree Jan 2004 A1
20040002760 Boyd et al. Jan 2004 A1
20040002769 Ferree Jan 2004 A1
20040006341 Shaolian et al. Jan 2004 A1
20040006344 Nguyen et al. Jan 2004 A1
20040010315 Song Jan 2004 A1
20040010318 Ferree Jan 2004 A1
20040019386 Ferree Jan 2004 A1
20040024400 Michelson Feb 2004 A1
20040024459 Ferree Feb 2004 A1
20040024460 Ferree Feb 2004 A1
20040024461 Ferree Feb 2004 A1
20040024462 Ferree et al. Feb 2004 A1
20040024469 Ferree Feb 2004 A1
20040024471 Ferree Feb 2004 A1
20040028718 Ferree Feb 2004 A1
20040030387 Landry et al. Feb 2004 A1
20040030389 Ferree Feb 2004 A1
20040030390 Ferree Feb 2004 A1
20040030391 Ferree Feb 2004 A1
20040030398 Ferree Feb 2004 A1
20040034357 Beane et al. Feb 2004 A1
20040044410 Ferree et al. Mar 2004 A1
20040049289 Tordy et al. Mar 2004 A1
20040059418 Mckay et al. Mar 2004 A1
20040059419 Michelson Mar 2004 A1
20040059429 Amin et al. Mar 2004 A1
20040068259 Michelson Apr 2004 A1
20040082954 Teitelbaum et al. Apr 2004 A1
20040082961 Teitelbaum Apr 2004 A1
20040087947 Lim et al. May 2004 A1
20040087950 Teitelbaum May 2004 A1
20040092933 Shaolian et al. May 2004 A1
20040092946 Bagga et al. May 2004 A1
20040092988 Shaolian et al. May 2004 A1
20040097927 Yeung et al. May 2004 A1
20040102848 Michelson May 2004 A1
20040111108 Farnan Jun 2004 A1
20040133229 Lambrecht et al. Jul 2004 A1
20040133280 Trieu Jul 2004 A1
20040138673 Lambrecht et al. Jul 2004 A1
20040153064 Foley et al. Aug 2004 A1
20040153065 Lim Aug 2004 A1
20040153146 Lashinski et al. Aug 2004 A1
20040167625 Beyar et al. Aug 2004 A1
20040172019 Ferree Sep 2004 A1
20050010292 Carrasco Jan 2005 A1
20050015152 Sweeney Jan 2005 A1
20050022839 Savas et al. Feb 2005 A1
20050033431 Gordon et al. Feb 2005 A1
20050038512 Michelson Feb 2005 A1
20050043796 Grant et al. Feb 2005 A1
20050070911 Carrison et al. Mar 2005 A1
20050080422 Otte et al. Apr 2005 A1
20050085910 Sweeney Apr 2005 A1
20050107863 Brown May 2005 A1
20050113919 Cragg et al. May 2005 A1
20050113928 Cragg et al. May 2005 A1
20050119561 Kienzle Jun 2005 A1
20050143827 Globerman et al. Jun 2005 A1
20050182463 Hunter et al. Aug 2005 A1
20050187558 Johnson et al. Aug 2005 A1
20050209698 Gordon et al. Sep 2005 A1
20050228391 Levy et al. Oct 2005 A1
20050228472 Case et al. Oct 2005 A1
20050240188 Chow et al. Oct 2005 A1
20050249776 Chen et al. Nov 2005 A1
20050261683 Veldhuizen et al. Nov 2005 A1
20050261695 Cragg et al. Nov 2005 A1
20050261768 Trieu Nov 2005 A1
20050261781 Sennett et al. Nov 2005 A1
20050278023 Zwirkoski Dec 2005 A1
20050278026 Gordon et al. Dec 2005 A1
20050278036 Leonard et al. Dec 2005 A1
20060004455 Leonard et al. Jan 2006 A1
20060015184 Winterbottom et al. Jan 2006 A1
20060022180 Selness Feb 2006 A1
20060036241 Siegal Feb 2006 A1
20060036273 Siegal Feb 2006 A1
20060052788 Thelen et al. Mar 2006 A1
20060052870 Ferree Mar 2006 A1
20060058807 Landry et al. Mar 2006 A1
20060058876 Mckinley Mar 2006 A1
20060058880 Wysocki et al. Mar 2006 A1
20060079898 Ainsworth et al. Apr 2006 A1
20060085069 Kim Apr 2006 A1
20060085070 Kim Apr 2006 A1
20060089715 Truckai et al. Apr 2006 A1
20060095123 Flanagan May 2006 A1
20060100706 Shadduck et al. May 2006 A1
20060106460 Messerli et al. May 2006 A1
20060122701 Kiester Jun 2006 A1
20060129244 Ensign Jun 2006 A1
20060142858 Colleran et al. Jun 2006 A1
20060142859 Mcluen Jun 2006 A1
20060149239 Winslow et al. Jul 2006 A1
20060149349 Garbe Jul 2006 A1
20060149385 Mckay Jul 2006 A1
20060155379 Heneveld et al. Jul 2006 A1
20060161261 Brown et al. Jul 2006 A1
20060178694 Greenhalgh et al. Aug 2006 A1
20060184188 Li et al. Aug 2006 A1
20060184248 Edidin et al. Aug 2006 A1
20060189999 Zwirkoski Aug 2006 A1
20060200166 Hanson et al. Sep 2006 A1
20060206207 Dryer et al. Sep 2006 A1
20060235414 Lim et al. Oct 2006 A1
20060235423 Cantu Oct 2006 A1
20060241764 Michelson Oct 2006 A1
20060253201 Mcluen Nov 2006 A1
20060264968 Frey et al. Nov 2006 A1
20060265077 Zwirkoski Nov 2006 A1
20060271061 Beyar et al. Nov 2006 A1
20060287725 Miller Dec 2006 A1
20060287726 Segal et al. Dec 2006 A1
20060287727 Segal et al. Dec 2006 A1
20060287729 Segal et al. Dec 2006 A1
20060287730 Segal et al. Dec 2006 A1
20070027363 Gannoe et al. Feb 2007 A1
20070032791 Greenhalgh Feb 2007 A1
20070043440 William et al. Feb 2007 A1
20070055201 Seto et al. Mar 2007 A1
20070055375 Ferree Mar 2007 A1
20070055377 Hanson et al. Mar 2007 A1
20070067034 Chirico et al. Mar 2007 A1
20070067035 Falahee Mar 2007 A1
20070093897 Gerbec et al. Apr 2007 A1
20070093899 Dutoit et al. Apr 2007 A1
20070112428 Lancial May 2007 A1
20070118222 Lang May 2007 A1
20070123877 Goldin et al. May 2007 A1
20070123986 Schaller May 2007 A1
20070162044 Marino Jul 2007 A1
20070162135 Segal et al. Jul 2007 A1
20070173824 Rosen Jul 2007 A1
20070173830 Rosen Jul 2007 A1
20070173939 Kim et al. Jul 2007 A1
20070173940 Hestad et al. Jul 2007 A1
20070208423 Messerli et al. Sep 2007 A1
20070213717 Trieu et al. Sep 2007 A1
20070219634 Greenhalgh et al. Sep 2007 A1
20070225703 Schmitz et al. Sep 2007 A1
20070233260 Cragg Oct 2007 A1
20070239162 Bhatnagar et al. Oct 2007 A1
20070244485 Greenhalgh et al. Oct 2007 A1
20070255408 Castleman et al. Nov 2007 A1
20070255409 Dickson et al. Nov 2007 A1
20070260270 Assell et al. Nov 2007 A1
20070260315 Foley et al. Nov 2007 A1
20070270956 Heinz Nov 2007 A1
20070270968 Baynham et al. Nov 2007 A1
20070276377 Yundt Nov 2007 A1
20070276382 Mikhail et al. Nov 2007 A1
20070282342 Niederberger et al. Dec 2007 A1
20070288028 Gorensek et al. Dec 2007 A1
20080015694 Tribus Jan 2008 A1
20080021558 Thramann Jan 2008 A1
20080021559 Thramann Jan 2008 A1
20080071356 Greenhalgh et al. Mar 2008 A1
20080077150 Nguyen Mar 2008 A1
20080082162 Boismier et al. Apr 2008 A1
20080124865 Lutze et al. May 2008 A1
20080125864 De Villiers et al. May 2008 A1
20080125865 Abdelgany May 2008 A1
20080133012 McGuckin Jun 2008 A1
20080140082 Erdem et al. Jun 2008 A1
20080140179 Ladisa Jun 2008 A1
20080140207 Olmos et al. Jun 2008 A1
20080147193 Matthis et al. Jun 2008 A1
20080147194 Grotz et al. Jun 2008 A1
20080183204 Greenhalgh et al. Jul 2008 A1
20080188941 Grotz Aug 2008 A1
20080208255 Siegal Aug 2008 A1
20080221687 Viker Sep 2008 A1
20080243254 Butler Oct 2008 A1
20080243255 Butler et al. Oct 2008 A1
20080249625 Waugh et al. Oct 2008 A1
20080249628 Altarac et al. Oct 2008 A1
20080281346 Greenhalgh et al. Nov 2008 A1
20080294205 Greenhalgh et al. Nov 2008 A1
20080312743 Vila et al. Dec 2008 A1
20080312744 Vresilovic et al. Dec 2008 A1
20090005871 White et al. Jan 2009 A1
20090012564 Chirico et al. Jan 2009 A1
20090018524 Greenhalgh et al. Jan 2009 A1
20090024204 Greenhalgh et al. Jan 2009 A1
20090024217 Levy et al. Jan 2009 A1
20090054991 Biyani et al. Feb 2009 A1
20090076511 Osman Mar 2009 A1
20090143859 McClellan et al. Jun 2009 A1
20090149956 Greenhalgh et al. Jun 2009 A1
20090163918 Levy et al. Jun 2009 A1
20090177207 Schaller Jul 2009 A1
20090182336 Brenzel et al. Jul 2009 A1
20090182431 Butler et al. Jul 2009 A1
20090198338 Phan Aug 2009 A1
20090234398 Chirico et al. Sep 2009 A1
20090240335 Arcenio et al. Sep 2009 A1
20090292323 Chirico et al. Nov 2009 A1
20090299378 Knopp Dec 2009 A1
20090318928 Purcell et al. Dec 2009 A1
20100004750 Segal et al. Jan 2010 A1
20100004751 Segal et al. Jan 2010 A1
20100016905 Greenhalgh et al. Jan 2010 A1
20100082109 Greenhalgh et al. Apr 2010 A1
20100125274 Greenhalgh et al. May 2010 A1
20100168748 Knopp et al. Jul 2010 A1
20100168862 Edie et al. Jul 2010 A1
20100191336 Greenhalgh Jul 2010 A1
20100211176 Greenhalgh Aug 2010 A1
20100262147 Siegal et al. Oct 2010 A1
20100292796 Greenhalgh et al. Nov 2010 A1
20100324560 Suda Dec 2010 A1
20110009869 Marino et al. Jan 2011 A1
20110009969 Puno Jan 2011 A1
20110029083 Hynes et al. Feb 2011 A1
20110046737 Teisen Feb 2011 A1
20110054621 Lim Mar 2011 A1
20110087296 Reiley et al. Apr 2011 A1
20110106260 Laurence et al. May 2011 A1
20110118785 Reiley May 2011 A1
20110125266 Rodgers et al. May 2011 A1
20110153019 Siegal Jun 2011 A1
20110166575 Assell et al. Jul 2011 A1
20110184519 Trieu Jul 2011 A1
20110218626 Krinke et al. Sep 2011 A1
20110230884 Mantzaris et al. Sep 2011 A1
20110230966 Trieu Sep 2011 A1
20110257684 Sankaran Oct 2011 A1
20110282387 Suh et al. Nov 2011 A1
20110282398 Overes et al. Nov 2011 A1
20110282453 Greenhalgh et al. Nov 2011 A1
20110319898 O'Neil et al. Dec 2011 A1
20110320000 O'Neil et al. Dec 2011 A1
20120004726 Greenhalgh et al. Jan 2012 A1
20120004731 Viker Jan 2012 A1
20120029518 Blackwell et al. Feb 2012 A1
20120071962 Huang et al. Mar 2012 A1
20120071980 Purcell et al. Mar 2012 A1
20130035723 Donner Feb 2013 A1
20130053852 Greenhalgh et al. Feb 2013 A1
20130085535 Greenhalgh et al. Apr 2013 A1
20130138214 Greenhalgh et al. May 2013 A1
20130173004 Greenhalgh et al. Jul 2013 A1
20130304224 Schmidt et al. Nov 2013 A1
20140088713 Greenhalgh et al. Mar 2014 A1
20140155980 Turjman et al. Jun 2014 A1
20150230931 Greenhalgh Aug 2015 A1
20150265417 Greenhalgh et al. Sep 2015 A1
20150351930 Greenhalgh et al. Dec 2015 A1
20160022429 Greenhalgh et al. Jan 2016 A1
20160030099 Greenhalgh et al. Feb 2016 A1
20160058572 Greenhalgh et al. Mar 2016 A1
20160310291 Greenhalgh Oct 2016 A1
20160374727 Greenhalgh et al. Dec 2016 A1
20170119540 Greenhalgh May 2017 A1
20170119541 Greenhalgh May 2017 A1
20170165083 Greenhalgh Jun 2017 A1
20170181865 Greenhalgh et al. Jun 2017 A1
20170196613 Greenhalgh et al. Jul 2017 A1
20170348115 Greenhalgh et al. Dec 2017 A1
20180256359 Greenhalgh Sep 2018 A1
20190231549 Greenhalgh et al. Aug 2019 A1
20190240043 Greenhalgh Aug 2019 A1
20190254714 Greenhalgh et al. Aug 2019 A1
Foreign Referenced Citations (100)
Number Date Country
19710392 Jul 1999 DE
0734702 Oct 1996 EP
0758541 Feb 1997 EP
1804733 Jul 2007 EP
2874814 Nov 2007 FR
2900814 Nov 2007 FR
2000-210315 Aug 2000 JP
2002-535080 Oct 2002 JP
2003-512887 Apr 2003 JP
2004-511297 Apr 2004 JP
2004-531355 Oct 2004 JP
2004-321348 Nov 2004 JP
2012-522961 Sep 2012 JP
662082 May 1979 SU
WO 1988003781 Jun 1988 WO
WO 1992014423 Sep 1992 WO
WO 1995031945 Nov 1995 WO
WO 1996003092 Feb 1996 WO
WO 1997000054 Jan 1997 WO
WO 2000025706 May 2000 WO
WO 2000030523 Jun 2000 WO
WO 2000044319 Aug 2000 WO
WO 2000044321 Aug 2000 WO
WO 2001032099 May 2001 WO
WO 2001078625 Oct 2001 WO
WO 2001095838 Dec 2001 WO
WO 2002013700 Feb 2002 WO
WO 2002032347 Apr 2002 WO
WO 2003003943 Jan 2003 WO
WO 2003003951 Jan 2003 WO
WO 2005062900 Jul 2005 WO
WO 2005096975 Oct 2005 WO
WO 2005120400 Dec 2005 WO
WO 2006023514 Mar 2006 WO
WO 2006023671 Mar 2006 WO
WO 2006026425 Mar 2006 WO
WO 2006028971 Mar 2006 WO
WO 2006034396 Mar 2006 WO
WO 2006034436 Mar 2006 WO
WO 2006037013 Apr 2006 WO
WO 2006042334 Apr 2006 WO
WO 2006050500 May 2006 WO
WO 2006060420 Jun 2006 WO
WO 2006068682 Jun 2006 WO
WO 2006072941 Jul 2006 WO
WO 2006076712 Jul 2006 WO
WO 2006086241 Aug 2006 WO
WO 2006096167 Sep 2006 WO
WO 2006116760 Nov 2006 WO
WO 2006116761 Nov 2006 WO
WO 2006132945 Dec 2006 WO
WO 2007009107 Jan 2007 WO
WO 2007009123 Jan 2007 WO
WO 2007016368 Feb 2007 WO
WO 2007038611 Apr 2007 WO
WO 2007041665 Apr 2007 WO
WO 2007041698 Apr 2007 WO
WO 2007047098 Apr 2007 WO
WO 2007050322 May 2007 WO
WO 2007056433 May 2007 WO
WO 2007062080 May 2007 WO
WO 2007073488 Jun 2007 WO
WO 2007075411 Jul 2007 WO
WO 2007076308 Jul 2007 WO
WO 2007076374 Jul 2007 WO
WO 2007076376 Jul 2007 WO
WO 2007076377 Jul 2007 WO
WO 2007079021 Jul 2007 WO
WO 2007084239 Jul 2007 WO
WO 2007084257 Jul 2007 WO
WO 2007084268 Jul 2007 WO
WO 2007084810 Jul 2007 WO
WO 2007100591 Sep 2007 WO
WO 2007113808 Oct 2007 WO
WO 2007123920 Nov 2007 WO
WO 2007124130 Nov 2007 WO
WO 2007126622 Nov 2007 WO
WO 2007130699 Nov 2007 WO
WO 2007131026 Nov 2007 WO
WO 2007133608 Nov 2007 WO
WO 2007140382 Dec 2007 WO
WO 2008005627 Jan 2008 WO
WO 2008016598 Feb 2008 WO
WO 2008036505 Mar 2008 WO
WO 2008070863 Jun 2008 WO
WO 2009039430 Mar 2009 WO
WO 2009067568 May 2009 WO
WO 2009114381 Sep 2009 WO
WO 2009130824 Oct 2009 WO
WO 2010013188 Feb 2010 WO
WO 2010121002 Oct 2010 WO
WO 2011014502 Feb 2011 WO
WO 2011049949 Apr 2011 WO
WO 2011142761 Nov 2011 WO
WO 2011149557 Dec 2011 WO
WO 2012027490 Mar 2012 WO
WO 2012040272 Mar 2012 WO
WO 2012083173 Jun 2012 WO
WO 2013028808 Feb 2013 WO
WO 2013119332 Aug 2013 WO
Non-Patent Literature Citations (7)
Entry
Choi, G. et al., “Percutaneous Endoscopic Lumbar Discemtomy by Transiliac Approach,” Spine, 34(12):E443-446, May 20, 2009.
Database WPI, Week 198004, Thomson Scientific, London, GB; AN 1980-A8866C, XP002690114,-& SU 662 082 A1 (Tartus Univ) May 15, 1979 (May 15, 1979), abstract, figures 1,2.
Franklin, I.J. et al., “Uptake of Tetracycline by Aortic Aneurysm Wall and Its Effect on Inflammation and Proteolysis,” Brit. J. Surger, 86(6):771-775, Jun. 1999.
Pyo, R. et al., “Targeted Gene Disruption of Matrix Metalloproteinase-9 (Gelatinase B) Suppresses Development of Experimental Abdominal Aortic Aneurysms,” J. Clinical Investigation,105(11):1641-1649, Jun. 2000.
Tambiah, J. et al., “Provocation of Experimental Aortic Inflammation Mediators and Chlamydia Pneumoniae,” Brit., J. Surgery, 88(7):935-940, Feb. 2001.
Walton, L.J. et al., “Inhibition of Prostoglandin E2 Synthesis in Abdonminal Aortic Aneurysms,” Circulation, 48-54, Jul. 6, 1999.
Xu, Q. et al., “Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium,” J. Biological Chemistry, 275(32):24583-24589, Aug. 2000.
Related Publications (1)
Number Date Country
20170319353 A1 Nov 2017 US
Provisional Applications (4)
Number Date Country
60617810 Oct 2004 US
60612001 Sep 2004 US
60612723 Sep 2004 US
60612724 Sep 2004 US
Continuations (2)
Number Date Country
Parent 14933820 Nov 2015 US
Child 15658173 US
Parent 11689465 Mar 2007 US
Child 14933820 US
Continuation in Parts (3)
Number Date Country
Parent PCT/US2005/037126 Oct 2005 US
Child 11689465 US
Parent PCT/US2005/034115 Sep 2005 US
Child PCT/US2005/037126 US
Parent PCT/US2005/034742 Sep 2005 US
Child PCT/US2005/034115 US